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ABSTRACT 
The call for early detection of hypertension and cardiac events creates a heavy 
demand for devices that can be used for blood pressure (BP) monitoring at home and in 
ambulatory systems. An emerging type of BP monitors without an occluding cuff has 
drawn great attentions for this application because it is wearable, comfortable and 
capable of providing continuous readings. 
Up-to-date, there is no defined and independent standard for wearable cuff-less BP 
measuring devices. Existing standards for evaluating sphygmomanometers are set up by 
the American Association for the Advancement of Medical Instrumentation (AAMI), the 
British Hypertension Society (BHS) and the European Society of Hypertension (ESH). 
They are only intended for devices that are used with an occluding or inflatable cuff and 
therefore, do not cover all aspects needed for the cuff-less devices. As a result, 
validating approaches of cuff-less devices vary largely from study to study, in terms of 
the evaluation protocol, statistical analysis and representation methods of the datasets. 
There is an urgent need to develop an evaluation standard for the wearable cuff-less 
devices that can be used by engineers and manufacturers to validate their products and 
by medical practitioners and lay-users to select prospective devices. 
The aim of this study is to establish a standard to assess the accuracy of cuff-less BP 
measuring devices, based on the experience of existing standards for evaluating 
conventional cuff-based devices and the experimental study on cuff-less devices. This 
paper attempted to contribute to the initiation of the standard from the aspects of 
evaluation protocol, statistical analysis and representation methods of the datasets. 
Firstly, a new distribution model, generalized t distribution with degree of freedom of 
four (t4), for measurement differences between the test device and the reference was 
proposed. We verified the model using evaluation results from 40 devices, of which 80% 
of the AAMI and BHS reporting results were in agreement, as compared to 50% if the 
original normal model was used. We further tested a cuff-less device on 85 subjects for 
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999 datasets and found that the differences between the proposed distribution and that of 
the device were non-significant for SBP measurements. 
Secondly, based on the t4 distribution model, mean absolute difference (MAD) or 
mean absolute percentage difference (MAPD) was recommended as a continuous scale 
to assess the accuracy of cuff-less devices. Based on the proposed distribution model, a 
map was developed to relate MAD with the criteria in A AMI, BHS and ESH protocols; 
for MAPD, it is prominent at evaluating devices that have errors increase with BP, 
which is an issue has not been fully explored in existing standards. 
Thirdly, since the physiological parameters in the estimation model of cuff-less BP 
devices are often subject dependent, a calibration procedure is required for each 
individual user before measurement. To evaluate whether a device has been properly 
calibrated, the evaluation protocol should require the test set to consist of BP data that 
distribute widely around the BP measured at calibration. We used data from two 
experimental studies: one carried out on 28 subjects with 139 datasets and another one 
on 85 subjects with 999 datasets. The analysis showed that breakdown of the 
performance evaluation of cuff-less devices according to the change of BP from the 
point of calibration is crucial for understanding and interpreting the overall accuracy of 
the device. 
To summarize, this work addressed several key issues concerning the evaluation of 
an emerging type of cuff-less BP measuring devices, i.e. the underlying error 
distribution model, the accuracy evaluation parameter, and the feature oriented 
validation protocol. The work can help to develop the standard for assessing the 
wearable cuff-less BP measuring devices, which aims to regulate the potential market of 
such devices and provide purchasers with reliable information in comparing and 
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的映射模型相比， t 4分布可更为准确的对两大标准的评估结果进行转换，转换正 
确率由原有的50%显著提高到80%。另外，文中还分析了无袖带血压仪的临床实验 
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Chapter 1. Introduction to Blood Pressure 
Measuring Devices and Evaluation Standards 
The call for early detection of hypertension and cardiac events creates a heavy 
demand for devices that can be used for blood pressure (BP) monitoring at home and in 
ambulatory settings. An emerging type of BP monitors without an occluding cuff has 
drawn great attentions for this application because it is comfortable and potentially 
capable of providing continuous readings. For the development the cuff-less devices, it 
is crucial to have an evaluation standard to assess the accuracy of them, and therefore 
this study is motivated. In the following chapter, I am going to briefly introduce the 
current situation on hypertension and BP measuring devices; and elaborate on the need 
of the study, state the objectives and map out the structure of this thesis. 
1.1. Current situation on hypertension 
A. Trevalknce offiypertension 
Hypertension is an important public-health challenge worldwide [1]. In 2000, the 
estimated global number of adults with hypertension was 972 million, 26.4% of the 
adults' population [1]. 
Hypertension is important not only because of its high frequency but also because it 
is a major modifiable risk factor for cardiovascular and kidney disease [1]. It was 
reported by WHO report 2002 [2] that, about 62% of strokes and 49% of heart attacks 
are caused by hypertension; 7.1 million die from hypertension which is about 13% of the 
global fatality in total.[3] 
方.£ow awareness offiyj^ertension 
Despite the risk people may face with hypertension, the unawareness and insufficient 
control rate of this disease is even toughing up the situation. The Joint National 
Committee report (JNC 7) [4] stated that the percentage of persons in whom 
hypertension is properly controlled (BP <140/90mmHg) are limited; more than 30% of 
小 
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the hypertensive populations are still unaware of their condition and therefore are not 
receiving treatment. Fig. 1-1 shows the unawareness rate for hypertension in the 
population aged 35-64 in five European countries, Canada and the U.S.A. in the past 
decade [5]. It can be seen that around 30-70% of the patients are unaware of their health 
situation. 
Sweden l ^ ^ a B B B v , : ， 5 2 . 0 0 % 
Spain 丄二 ,】61•拠 
Italy 丄 丄 ] 4 8 ^ ， 
Germany ^ ^ I t S I ^ ^ M ： . , " “ . . • „ ,3163.50% 
England 二丄:,•二,‘二 ： ： 
Canada 幸 “ • " ― 丄 , 3 6 . 8 0 % 
U S A 
Z • 1 • 1 • • • I • • 
0®/® V^。/o tJO。/。明。/。1^0"。明0/。谈。/。•込0。/。90。/。—。 
Fig. 1-1. Hypertension unawareness in the population aged 35-64 years in five 
European countries, Canada and the U.S.A. in the past decade. The graph is 
plotted based on data reported in [5】. 
1.2. Calls for better management of hypertension 
BP measured in a clinical setting by a trained physician using the auscultative 
technique with the mercury column has been used as the standard parameter for clinical 
diagnosis for over 100 years [6]. It is however becoming increasingly clear that this 
reading is often inadequate or even misleading to represent a patient's true BP status [6]. 
On the other hand, ambulatory BP measurement (ABPM) and home (or self) BP 
measurement (HBPM) are shown to be superior to clinic BP measurement (CBPM) in 
predicting cardiovascular mortality, as demonstrated in Fig. 1-2; and the nighttime BP is 
the most potent predictor of the outcome [7]. 
� 2 � 
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Fig. 1-2. Adjusted 5-year risk of cardiovascular death in the study cohort of 
5292 patients for clinic blood pressure measurement and ambulatory blood 
pressure measurement. The 5-year risks are expressed as number of deaths per 
100 subjects [7]. 
Comparing to CBPM, ABPM and HBPM have the following advantages [4,8-9]: (1) 
eliminate the white-coat effect; (2) helpful to the assessment of clinic effects, drug 
effects and work influence on BP; (3) better predict cardiovascular events and mortality; 
and (4) cost effective. 
Therefore, in 2008, the American Heart Association (AHA), American Society of 
Hypertension (ASH), and Preventive Cardiovascular Nurses Association (PCNA) 
published a joint scientific statement that called to an action on using HBPM and 
recommended that HBPM should become a routine component of BP measurement in 
the majority of patients with known or suspected hypertension [6]. 
1.3. Blood pressure measuring devices 
Jl Conventwnaf � i c e s andt/teir limitations 
Current devices employed for ABPM and HBPM are usually developed based on the 
oscillometric method, which has to be used with an inflatable cuff during measurement. 
Those systems have several drawbacks which hinder their popularizing in the broad 
masses. 
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One of the major problems is the employment of an inflatable cuff during the 
measurement. Patients find the cuff pressure is intolerable, particularly those with very 
high BP and need frequently repeated readings; petechiae of the upper arm and bruising 
under the inflating cuff may occur; sleep disturbance is fairly common. 
Moreover, to have an accurate measurement, an appropriate cuff size must be 
selected according to the upper-arm circumference of users [10]. Applying a cuff that is 
inappropriately small or large against the upper-arm circumference will contribute a 
substantially false elevation or reduction to the BP readings [10]. Educating users with 
appropriate sized cuff for the out-of-office BP measurement is necessary [10], which is 
however an additional workload to the nurses. 
Last but not least, the readings by conventional devices may be insufficient indicators 
for hypertension. Since only intermittent measurements of single snap-shot readings are 
provided, current devices are incapable of recording the time varying BP or capturing 
the dynamic state of the cardiovascular system throughout the day [11]. Besides, study 
on pathogenesis of hypertension reveal that, the systolic hypertension is much dependent 
on a series of changes in the vasculature, the most important of which is increased 
central arterial stiffness [12]. Those signals are difftised by the relative imprecision in 
the techniques utilized by current devices [12]. 
% ^aroBlk cuff-lkss dkvkes 
In the past few years, there was an emerging interest in developing non-invasive BP 
measuring devices without an occluding cuff. Leading investigators in this field suggest 
that BP can be estimated indirectly from pulse transit time (PTT) which is the time taken 
for the pulse wave to travel along the artery and arrive at the periphery. Models that 
relate BP and PTT have been developed based on many physiological parameters, e.g. 
elastic modulus, dimensions and stiffiiess of the intervening vessels. Experimental 
results have also shown that the relationship is approximately linear [11,13-15]. 
Based on these models, systems that use electrocardiogram (ECG) and/or 
photoplethysmograph (PPG) sensors have been proposed for the cuff-less and 
continuous measurement o fBP [11,16-17]. Some of them are shown in Fig. 1-3. 
〜4〜 
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Fig. 1-3. Some of the wearable cuff-less blood pressure measuring devices 
developed by (a) D'arbeloff Lab at MIT [11】，（b) JCBME at CUHK and (c) Philips® 
Cuff-less BP measuring devices successfully release the users from the cuffs and are 
therefore more suitable to be implemented into the HBPM or ABPM systems, where 
frequent measurements are usually needed. When they are designed as wearable devices, 
e.g. a shirt [18] or watch [19-20], or integrated with furniture at home, e.g. a chair [21] 
or bed [22], the long-term and out-of-office monitoring becomes more comfortable and 
thus more attractive to the patients. 
In addition, those devices have the great advantages of not only capable of providing 
a snapshot of BP, but also potentially usable for continuous BP monitoring. This special 
feature makes them superior to CBPM for the prompt identification of cardiovascular 
risk. Besides, since signals, e.g. arterial stiffiiess, are implemented into the estimation 
model, the cuff-less devices are potentially more capable of providing informative 
indication of the patient's health condition. 
Nevertheless, since the physiology coefficients employed for BP estimation are 
subject-dependent, calibration is crucial to ensure the accuracy of the cuff-less devices. 
A major challenge of them is to find a simple and accurate way to calibrate it 
individually or estimate BP directly without a calibration procedure. [23][15]. 
The above comparison between cuff-less devices and the conventional cuff-based 
ones are summarized in Table 1-1. 
� 5 � 
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TABIJi； 1-1. COMPARISON BliinniJ:!^ CIJUUKXT LMDIXG SELF AM) 
AMBULATORY DIUVICF.S WITH THK IHMFJIGING CIJFF-LKSS DIUVICES. 
Conventional devices Cuff-less devices 
Unsuitable to be implemented into More suitable to be designed as 
Wearability wearable settings due to the need wearable devices for long-term 
cuffs during measurement. and out-of-office monitoring. 
Applying a cuff with inappropriate Calibration of the subject-
Potential size against the arm circumference dependent physiology coefficients 
Error will contribute a substantially error used for BP estimation is crucial 
to the readings. for maintaining the accuracy. 
Only intermittent measurements Potentially capable of providing 
Reading of single snap-shot readings. continuous measurement of BP. 
1.4. Evaluation of the wearable cuf•丨ess devices 
up-to-date, there is no defined and independent standard for wearable cuff-less 
devices. Existing standards for evaluating sphygmomanometers are set up by the 
American Association for the Advancement of Medical Instrumentation (AAMI) [24-26], 
the British Hypertension Society (BHS) [27-28] and the European Society of 
Hypertension (ESH) [29]. Those standards for evaluating sphygmomanometers are only 
intended for devices that are used with an occluding cuff and therefore, do not cover all 
aspects needed for the emerging cuff-less devices. As a result, validating approaches of 
the cuff-less techniques or devices vary largely from study to study. 
Since cuff-less approaches has become of such importance in hypertension research 
in recent years that, it merits a section to itself in the assessing process and it is crucial 
for the clinicians and engineers to joint efforts in establishing an evaluation standard. 
The IEEE has approved to initiate such a standard "A protocol for the Evaluation of 
the Wearable Cuff-less Blood Pressure Measurement Devices" (IEEE PI708) in 2006. 
The work in the thesis will be implemented into this standard. Hopefully, the standard 
will serve as a guideline for manufacturers to qualify and validate their products; for 
potential purchasers or users to select their prospective products; and also for health care 
~ 6 ~ 
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professionals to understand the manufacturing practices when using these devices for 
diagnosis. 
On the other hand, although existing standards for evaluating sphygmomanometers 
are developed for devices with an occluding or inflatable cuff, parts of them are still 
applicable to the evaluation of cuff-less devices. The experiences of these current 
standards need to be carefully appreciated during the development of the new standard. 
1.5. Obiectiues Of the thesis 
An evaluation standard should at least comprise of a validation procedure, a statistical 
analysis and representation of the data. Therefore, the study aims to contribute to the 
initiation of this standard from the aspects of: 
• examine the error distribution of various BP measuring devices; 
• select some parameters for assessing the accuracy of cuff-less devices; 
• design a validation protocol that meets the special features of cuff-less devices. 
1.6. Structure Of the thesis 
According to the objectives of the study, the rest of the thesis is organized as follows: 
chapter 2 reviews current standards on evaluating conventional BP measuring devices; 
chapter 3 examines the error distribution for bosh cuff-based and cuff-less devices; 
chapter 4 proposes some continuous scales for assessing the accuracy of cuff-less 
devices and builds up the relationship with the current standards; chapter 5 discussed the 
necessity of designing a validation protocol with BP changes from the calibration point; 
finally, chapter 6 proposes an integrated protocol and data analysis method based on the 
previous study, concludes with the major points and discusses the future work. 
〜7~ 
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Chapter 2. Review on Current Standards 
Existing standards for evaluating sphygmomanometers are set up by AAMI, BHS and 
ESH associations. The experience with these original standards for validating cuff-based 
devices provide valuable insight into the methodological problems associated with the 
validation of cuff-less devices. Therefore, we will do a comprehensive review on the 
current standards and figure out the major challenges for the evaluation of BP devices, 
especially the cuff-less ones. 
2.1. Introduction to current standards 
� JLAMf stamiard' 
The AAMI standard was first published in 1987 [24] for the validation of electronic 
or automated sphygmomanometers used with an occluding cuff, and revised twice in 
1993 [25] and 2002 [26] respectively. Statistical mean difference (MD) and standard 
deviation of differences (SD) between the measurements obtained by a test device and 
the reference are used as the evaluation parameters. The validation shall be conducted on 
at least 85 subjects, each of whom contributes 3 measurements. In the latest version of 
AAMI [26], these data can be analyzed in two ways. Method 1 requires MD and SD of 
all measurement differences (N = 255) be within 士 5 mmHg and 8 mmHg respectively. 
Method 2 averages the 3 readings of each subject and reduces the allowable value of the 
SD as the MD increased [26]. 
% 3J{Sj7rotocoC 
The BHS protocol was first established in 1990 [27], primarily to address the testing 
of ambulatory BP monitoring devices. A revision of the protocol was published in 1993 
with the intention to make the method more applicable to devices for intermittent 
monitoring of BP [30]. The criteria for acceptance were relaxed from the 1990 protocol. 
The validation protocol is similar to that of AAMI, e.g. testing on 85 subjects, each 
contributes 3 measurements, but the analysis approach is very different. BHS grades a 
Chapter 2. Review on Current Standards 
device according to the cumulative percentages (CP) of absolute differences between a 
test device and the reference that fall within 5，10 and 15 mmHg (CPs, CPio and CP15). 
A device is classified into a certain grade only if it satisfies the requirement on all these 
three parameters. 
C TS^^jn^otocof 
The ESH protocol was established in 2002 [31] based on the BHS studies in an 
attempt to simplify the testing procedures. The validation procedure was divided into 
two phases: 15 subjects for phase 1 and an additional 18 subjects for phase 2, where 
each subject contributes 3 measurements. There is a recent -concern raised on the 
applicability of this protocol, for that the statistical power is significantly reduced due to 
the reduced sample size [32]. We therefore focus mainly on the statistical reasonability 
and judging criteria for AAMI and BHS protocols, and refer only to the later aspect for 
ESH protocol. 
2.2. Comparison of current standards 
AAMI, BHS and ESH protocols, which differed in detail, had a common objective: 
the standardization of validation to establish minimum standards of accuracy and 
performance and facilitate comparison of one device with another [33]. Although the 
protocols have many similarities, there are differences of considerable practical 
importance to manufacturers who may wish to have their devices validated according to 
criteria acceptable to both the European and the American markets [34]. In the following 
part, some of the major differences will be compared with the latest versions of the three 
protocols. 
Jl ^Eva/uatwn scoj:?e 
The AAMI standard establishes labeling, safety, and performance requirements for 
nonautomated, automated or electronic sphygmomanometers that are used with an 
occluding cuff for the determination of BP. In the latest version of the standard, the 
assessment of ambulatory systems is also included. 
—Q — 
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Unlike AAMI standard, BHS and ESH protocols focus on the assessment of 
accuracy performance for automated or semi-automated BP measuring devices with an 
occluding cuff. The BHS protocol was modified with special provisions to make it more 
applicable to the evaluation for ambulatory systems. 
yaCtdatwnprotocof 
The complete AAMI standard consists of eight parts: 1) requirements, 2) tests 3) 
rationale for the development and provisions of the standard, 4) verification against 
manual auscultatory measurements, 5) verification against intra-aiterial measurements, 6) 
data analysis and reporting, 7) assessment of ambulatory systems and 8) statistical 
considerations. 
On the other hand, the BHS protocol is divided into five parts, including 1) main 
validation procedures, 2) validation for special groups and in special circumstances, 3) 
observer training and assessment, 4) statistical considerations, and 5) providing of basic 
information. The main validation procedure consists of five parts, which are: i) before-
use calibration, ii) in-use assessment, iii) after-use calibration, iv) static device 
validation and v) grading of devices. The steps (i)- (iii) were introduced to identify intra-
device variability before the real validation phase, and aims to overcome the problem of 
devices losing accuracy under the stress of everyday use. In the AAMI standard, these 
steps were only recommended for the evaluation of ambulatory systems. 
The validation procedure of ESH protocol consists of five steps: 1) observer training 
and assessment, 2) familiarization session, 3) validation measurements, 4) analysis and 5) 
reporting. The validation measurements are further divided into two phases. The pre-
validation steps (i)-(iii) required in BHS protocol were eliminated, for that they were 
considered as unnecessary procedures. Both ESH and BHS protocols are more elaborate 
in that it takes particular care to ensure the observers trained to a very high standard. 
C Accuracy criteria 
In the AAMI standard, there are two methods for evaluating the accuracy of the 
devices. Method 1 requires MD and SD of all measurement differences (N = 255) be 
within 土 5 mmHg and 8 mmHg respectively. There were concerns from clinicians that 
-10-
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the devices that passed the method 1 at the margins (i.e. a large MD and a large SD) 
could produce readings with large errors. To address this concern, method 2 was 
introduced. It averages the 3 readings of each subject and requires the MD of the 
averaged values (N = 85) to be within 土 5 mmHg and SD of them to be less than a limit 
that is tightened as the reported MD increases. Table 2-1 presents the upper limit on the 
SD of paired differences for given values of the mean of the paired differences. 
TABLK 2-1. OUTFJUA FOU METIIOl) 2 OF THK AAMI STAM)AU» (2002) [2(J� . 
Mean 
Difference 〇 土 0.5 ±1.0 ±1.5 土 2.0 士 2.5 ±3.0 ±3.5 ±4.0 ±4.5 士 5.0 
(mmHg) 
Standard 
Deviation 6.95 6.93 6.87 6.78 6.65 6.47 6.25 5.97 5.64 5.24 4.81 
(mmHg),< 
Although the BHS protocol required the same number of measurements as the AAMI 
protocol, the acceptance criteria were different. The BHS protocol specified a grade for 
systolic and diastolic measurements on the basis of the percentage of absolute 
measurement errors within specified boundaries. In the revised version of BHS protocol 
1993，the criteria for acceptance were relaxed from the 1990 protocol and are shown in 
Table 2-2. Devices with a grade less than "B" were not considered to be acceptable. 
TABLE 2-2. GllADIXC CIUTERIA FOR BHS PROTOCOL ( 1 9 9 3 ) � 3 0 � 
Absolute difference between standard and test device 
Grade 
mmHg <10 mmHg mmHg 
Cumulative percentage of readings 
A 60 85 95 
B 50 75 90 
C 40 65 85 
D Worse than C 
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The ESH protocol requires measurements on 33 participants, with three 
determinations from each participant. Instead of applying grading criteria, the ESH 
protocol substituted the pass/fail criteria shown in Table 2-3. At the completion of this 
test, the device must pass the criteria of phase 1 and phase 2.1 (overall performance) and 
phase 2.2 (intra-subject variability). Phase 2.2 is special in ESH protocol for that, both 
AAMI and BHS protocols fail to describe the extent to which approved BP devices will 
generate accurate readings in individual patients [35]. The protocol states the 
requirements in terms of ratios, and we have included percentages to allow comparison 
with other protocols. The requirements of the second phase (on a percentage basis) 
equals to grad A of the BHS protocol. • 
TABIJi： 2-3. ACCURACY ClUTliillLI FOR ESH PROTOCOL (2002) [31] 
Absolute difference between test and reference measurements 
<5 mmHg (%) <10 mmHg (%) <15 mmHg (%) 
Phase 1:15 subjects 
Requirements to pass phase 1 
At least one of 25(56) 35(78) 40(89) 
Phase 2:33 subjects 
Requirements to pass phase 2.1 
Two of 65 (66) 80(81) 95 (96) 
All of 60 (61) 75(76) 90 (91) 
Requirements to pass phase 2.2 
Subjects 2/3 within 5 mmHg 0/3 within 5 mmHg 
At least 22 
At most 3 
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TK Testing reference 
The kAMl standard regards the mercury sphygmomanometer and intra-arterial BP 
measurement methods as the two optional approaches for the reference standard, and 
stipulates testing procedures of overall systems efficacy by comparison against them 
respectively. When the mercury sphygmomanometer method is the reference standard, it 
is required that the two trained observers make simultaneously blind BP determinations 
on each subject, and the observer's individual values for each reading shall be averaged 
for calculation purposes. 
For the BHS protocol, only the non-invasive mercury sphygmomanometer is 
recommended. While it is also required to record readings by two observers 
simultaneously, the readings are not averaged but analyzed separately. The reference 
reading that is more favorable to the tested device is selected. 
The ESH protocol employs similar procedure as BHS protocol. While it uses 
different ways of analysis that, the simultaneously readings from the two observers are 
averaged first; of the two averaged reference values collected before and after the test 
device, the one that is more favorable to the tested device is selected. 
I , ！Recruitment ofsuBjects 
The selection procedure of subjects shall strive for introducing no bias to the 
evaluation result by covering the whole range of BP in the validation, since some 
devices tend to be less accurate with increasing BP [36]. 
AAMI, BHS and ESH protocols put requirement on BP range in three, five and three 
intervals respectively. The endpoints for the BP intervals defer from protocol to protocol 
without a uniform definition, as shown in Table 2-4. 
All the three protocols have requirements for the BP ranges of the subjects to 
represent that of the population. Comparing to the AAMI standard, the BHS and ESH 
protocols require more subjects to have their SBP or DBP in the extremely high regions: 
33% of the subjects' SBPs need to be over 160mmHg, and 33% of the subjects' DBFs 
need to be over 100 mmHg; while AAMI standard only requires 10% in each range. 
� 1 3 � 
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Comparing to the other two protocols, the BHS protocol requires more SBP in extremely 
low ranges, which is 10% lower than 90mmHg. 
TABLK 2-4. lllHOlJIUEMliiXTS OX THK UIHClUJITMIiiXT OF SIJIMIUCTS IIV THE 
ClJlUUiilVT Sm\l)AUI)S. 
Standard No. Requirement on Subjects' BP Range Others 
^ <100 100-160 > 1 ^ range of 
N at least 10% remainder at least 10% arm size A AM I 85 
[26] DBP <60 60-100 >100 
N at least 10% remainder at least 10% 
SBP <90 90-129 130-160 161-180 >180 NA 
BHS 85 N 8 20 ^ 20 8 
[30] DBP <60 60-79 80-100 101-110 >110 
N 8 20 ^ 20 8 
Low Medium High gender 
ESH SBP 90-129 130-160 161-180 
phase 2 33 
[31] DBP 40-79 80-100 101-130 
N 11 11 n 
J\ jAmBulatory monitors 
The AAMI standard defines ABPM as portable, lightweight, automated devices worn 
or carried by the patient that are able to obtain and store the results of repeated 
determinations of BP and heart rate during activities of ordinary daily living [26]. 
However, there are several issues should be noted: 1) in fact, current ambulatory systems 
in the market do not measure ambulant BP but rather the BP at rest intermittently over 
the 24h period; 2) there is no obligation on manufacturers to have such devices validated 
independently, even though current standard development associations call for doing so 
[37]; 3) many factors can influence the validation procedure [37], and the most difficult 
one is the assessment of ABPM during motion due to that the only precise standard 
measurement of BP during exercise is intra-arterial recording. 
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The AAMI standard suggested two testing issues in addition to the tests required to 
the normal kind of devices, including the validity assessment of during motion and 
reliability during clinical use in the field. If the manufacturer desires to label the device 
as "precise during repeated ambulatory determinations", the validity and accuracy 
during motion, i.e., bicycle exercise or ambulatory activity, should be assessed against 
the intra-arterial measurement. The validation procedure should also include equal 
numbers of measurements in three different positions, i.e., supine, seated, and standing. 
Another special consideration for ABPM is the potential loss of precision during clinical 
use. Since ABPM are subject to greater wear and tear during clinical use than are non-
portable pressure recorders, the assessment should include tests before and after 24h 
study. However, no explicit protocol is stipulated in the standard. 
The BHS protocol also stipulates an optional phase that, if devices are claimed to be 
accurate during exercise, separate validation must be performed to assess their accuracy 
under exercise conditions. The protocol requires 30 subjects to be recruited, and exercise 
according to modified Bruce protocol at level 2 and level 5 for 5-6min; SBP is recorded 
simultaneously with the test device and a mercury sphygmomanometer 3 times at each 
exercise level. Comparison of BP measuring systems that utilize indirect measurement 
with direct intra-arterial measurement of BP is not recommended in the BHS protocol 
for the ethical considerations. Moreover, the in-use validation is recommended to all 
devices before the real validation phase in order to overcome the problem of devices 
losing accuracy under the stress of everyday use, while this is only recommended for the 
validation of ABPM in the AAMI protocol. 
Q, SjjectaCgroups ofj?ojmlatwn 
It was observed from the study [38] that discrepancies between an ambulatory system 
and a mercury standard were systematically related to characteristics of the participating 
subjects, such as age, gender and race, with age demonstrating the strongest correlation. 
Besides, hypertension is found to occur in more than two thirds of individuals after age 
65 years who is also the population with the lowest rates of BP control [4]. It is therefore 
suggested that ambulatory systems for use in the elderly should be evaluated specifically 
in an aged population. Since the experience in validating BP measuring devices in these 
� 1 5 � 
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special circumstances is limited, the related recommendations are regarded as somewhat 
tentative. 
The AAMI standard [26] has a general provision for devices intended for use in 
populations of adult populations (>12 years old), adult/pediatric populations (>3 years 
old), neonate, infant, and pediatric populations (<3 years old). The validation procedure 
are similar for different groups of populations, except that 1) for children less than 3 
years old, intra-arterial method shall be used as the reference standard; and 2) in 
children 12 years old and younger, whether DBP is identified using the or 
Korotkoff sound shall be specified by the manufacturer. 
The BHS protocol [30] also provides validation procedure for special group of 
population in addition to its main validation procedure. These special groups of 
population include, the pregnant women, elderly (>65 years old), young children (<5 
years old) and older children populations (5-15 years old). Compared to the general 
provisions, the main change for this part is that only 30 subjects are needed, and the 
required BP range and arm circumference are also adjusted accordingly. 
The ESH protocol [31] is confined to adults over the age of 30 years, as these will 
constitute the majority of subjects with hypertension, and does not make 
recommendations for special groups. 
J{. Statistwaf consideratums 
The statistical criteria in the AAMI standard were developed in conjunction with 
clinicians who were experts in BP measurement, and the diagnosis and treatment of 
hypertension. Under normal distribution, the sample size is determined. According to the 
calculation, a sample size of 85 yields a 90% chance that the estimated probability of a 
tolerable error (within ±10 mmHg) will not differ by more than about 7% from its true 
probability. In addition, the method 2 was developed according to the rule of making 
sure that at least 85 % of the measurement error is within a tolerable error of ±10 mmHg. 
This rule makes the upper limit for an acceptable sample SD depend on the sample MD. 
The BHS protocol carried on the sample size from the AAMI standard. The required 
proportion of measurement errors that would lie within 5，10 and 15 mmHg were laid 
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down by assuming a SD of 6，8，10 mmHg, for grades A, B and C, respectively. These 
percentages were then rounded for convenience, and to allow for occasional aberrant 
readings, the percentages required within 10 and 15 mmHg were lowered. 
Moreover, since both AAMI and BHS protocols were developed based on the 
assumption that the measurement errors follow a normal distribution, Sun and Jones [39] 
developed a statistical map to relate the AAMI criteria (i.e., MD and SD) with the BHS 
grading criteria (i.e., grades A, B, C, and D). When comparing this map with validation 
results from published literatures [40], it was [41] however found that they do not agree 
with each other in all circumstances. 
The ESH Protocol was developed to provide a "simplified" test for determining the 
accuracy of BP measuring devices. The sample size of 33 reduces the power of the test 
to 70% [32]. This significant reduction in statistical power casts doubt that the ESH 
protocol is of use to determine the accuracy of BP devices within the tolerance required 
by clinicians and increases the risk of failing to reject an inaccurate device. Although the 
protocol makes device testing easier, the users cannot sanction its use in preference to 
the BHS and AAMI protocols. It is for these reasons that the International Standards 
Organization Sphygmomanometer Committee did not include the ESH protocol in its 
current standard [32]. 
2.3. Major challenges for the evaluation of cuff-less devices 
Based on the previous discussion, the review and comparison of the current standards 
are summarized in Table 2-5. 
The experience with the current standards by AAMI, BHS and ESH for validating 
conventional cuff-based BP measuring devices has provided valuable insight into the 
methodological problems associated with device validation. On the other hand, the 
review on those standards expose some crucial challenges that need to be solved during 
the development standard, especially a standard that is intended to be used for the 
evaluation of cuff-less BP measuring devices. 
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TABIJj： 2-5. SlJMMARIZli：!) COMPARISON OF AAMI, BHS AM) ILSH PROTOCOLS 
AAMI standard BHS protocol ESH protocol 
A. Evaluation Scope 
labeling, safety, and performance , . , 
. ‘ accuracy performance for automated or semi-
. , automated BP measuring devices and 
sphygmomanometers and , , ^ ^ 
, , ambulatory systems 
ambulatory systems 
B. Distinctive Validation Procedure 
validation for special groups; in-use assessment; observer training; 
in-use assessment for ABPM; validation for special 2 phases of 
no observer training. groups and in special validation. 
circumstances; 
observer training. 
C. Accuracy Criteria 
Method 1, all differences: Grading into A, B, C and D Criteria in terms of 
I MD|<5mmHg and SD<8mmHg according to percentage ratios for overall 
Method 2, average for each of absolute measurement performance and 
subject: |MD|<5mmHg, SD differences within 5,10, intra-subject 
tightened as MD increases. 15 mmHg. variability. 
D. Testing Reference 
mercury sphygmomanometer or , • 
' . , 各 only mercury sphygmomanometer intra-arterial measurement 
E. Recruitment of Subjects 
85 subjects; 85 subjects; 33 subjects; 
specified BP ranges; specified BP ranges. specified BP ranges; 
specified arm circumstances. required gender. 
F. Ambulatory Monitors 
、 . 」 “ L 1) 30 subjects; 
1 test during motion and at three . 
‘ “1« . ‘ + • I 2 exercise according to 
postures against the intra-arterial . „ b 
^ 5 modified Bruce protocol; NA 
measurement; . . ^ . , . 
2) test before and after 24h study. 3) test agams indirect 
‘ measurement. 
G. Special Groups 
. , pregnant women; 
adult; elderly; 
adult/pediatric; young children; NA 
neonate； infant, and pediatric. children 
H. Statistical Considerations 
• •」• 1 Based on normal 
Based on normal distribution, .. ^ . . 丄 . . 
. , I distribution, the criteria 
acceptance criterion and sample , ,. NA 
^ . , . . for grading were 
size were determined. , ^ . , 
determined. 
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Jl XacH ofe^ertmentafc(ata 
With the developing interests and a vast market for wearable cuff-less devices, there 
is however no standardized regulation that provides guidelines for manufacturers and 
researchers to have their devices validated independently. Because of the lack of 
experienced data or specialized study on the evaluation of such devices, it is difficult to 
quantify the accuracy limit for the cuff-less devices. Therefore, it is necessary to propose 
a standard and encourage the device developers to have their products evaluated and 
reported on a uniform basis. 
% 拟-examination of tfie statisticaf cansidkratiom 
The statistical basis of the existing protocols varies significantly in the aspects of 
evaluation parameter and accuracy criteria. Although they were developed on the same 
basis of normal distribution, this assumption is however found problematic from many 
studies. It is therefore necessary to re-examine the statistical background based on 
clinical experiments, and use it as a rule for the standard development. 
C, feature orientecC如ign o f t f i e vaCidationjrrotocoC 
Since cuff-less devices use completely different measurement techniques as 
compared to those of the conventional cuff-based ones, the current standards do not 
cover all aspects of these devices. For example, to determine the subject-dependent 
coefficients for the estimation of BP, cuff-less devices often require an individual 
calibration procedure. The efficacy of the calibration would greatly influence the device 
accuracy. Therefore, special validation procedures shall be designed to cover these 
distinctively new features and assess them properly. 
V. Selection of testing reference 
The validation reference employed in the current standards is BP reading obtained by 
an observer using mercury sphygmomanometer. These readings are vulnerable to BP 
variations and will induce errors when assessing the ambulant systems during motion. 
Although the continuous measurement of intra-arterial pressure is the most precise 
method of assessing an ABPM, its use is highly restricted. It is therefore hopefully that 
other techniques would be developed to take place the existing reference standards. 
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In the following chapters, we will mainly focus on the re-examination of the 
statistical considerations and the design of a feature-oriented validation protocol, and 
hopefully that this work would ultimately encourage the publication of more studies on 
the experimental results from cuff-less devices. 
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Chapter 3. Error Distribution Model 
Distribution modelling is the foundation for the development of a standard. Based on 
a certain assumption of distribution model, requirements such as accuracy thresholds 
and sample size can be justly determined. Several studies have revealed that, current 
standards may base on an inappropriate assumption of distribution which leads to some 
problems when interpreting the validation results from different standards. Therefore, to 
make sure that a proper distribution assumption is employed when evaluating the BP 
measuring devices, we intend to re-examine the error distribution model using both 
theoretical and experimental approaches. Since there have not been any standards 
developed for wearable cuff-less devices, the study was conducted based on existing 
standards of BP monitors, even though they were developed for cuff-based devices. 
3.1. Distribution assumption in current standards 
The determination of the underlying error distribution is crucial for the establishment 
of a standard. Both the AAMI and BHS evaluation systems are developed based on the 
assumption that the measurement errors are normally distributed [26,30]; the thresholds 
were also laid down according to this distribution. Under the assumption of normal 
distribution, Sun and Jones [39] developed a statistical map to relate the AAMI criteria 
(i.e., MD and SD) with the BHS grading criteria (i.e., grades A, B, C, and D). This map 
showed that a device that has achieved grade A or B under the BHS system should deem 
to comply with the AAMI standard. We [41], however, found in the literature [40] that 
there were devices which have passed the criteria of BHS but failed that of AAMI. 
Sun and Jones [39] also found a significant discrepancy between the sample CP5, 
CPio and CP15 and their theoretical values estimated from the sample MD and SD. 
Consequently, when a normal distribution model was employed, more than half of the 
67 test entries collected from literatures would be downgraded in the BHS system if the 
CP values were estimated from the reported AAMI parameters [39]. 
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In short, the results were suggesting that a normal model may not be a good 
approximation of the underlying distribution of the experimental data. Therefore, other 
distribution models should be introduced to re-examine the statistical backgrounds for 
these two standards; the goodness-of-fit test shall be conducted to test whether the new 
distribution model fits the experimental data. 
3.2. Distribution analysis from published reports 
Jl Metfiodblbgy 
To solve the problem raised from the study of Sun and Jones [39], the generalized t 
distribution was proposed [41], which is a function of MD (m), scale (s) and degree of 
freedom (v) with the following form of probability density function (PDF, p) [42]: 
s r ( - r - ) (卜以 j i i 
z X ( l + — 2 ， (3-1) 
where r( .) denotes the Gamma function. As the value of v grows, the generalized t 
distribution approaches the normal distribution. 
Comparing to normal distribution, generalized t distribution introduced another 
parameter, degree of freedom, which controls the shape of the PDF in terms of the 
heights of peak and the thickness of tail. This property makes the t distribution 
prominent at identifying outliers. 
A comprehensive search was performed in the Medline database for literatures 
published during 1991 to 2008 on the evaluation of BP devices by the BHS protocol and 
the AAMI standard [43]. It is assumed that the error distributions of the devices follow 
either a normal distribution or generalized t distribution of a certain degree of freedom. 
The CP values specified in the BHS protocol were obtained by integrating the PDF over 
the required range of limits (L). The equations used for the estimation are as follows: 
For normal distribution, its PDF is defined as, 
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1 -{X-uf 
p(x\u,d)dx = j ^ e ； (3.2) 
so the CP values under normal distribution is, 
CP,^' (w, J , L) = f pix I M, d)dx = -—^ f e 办 . 
where d denotes the SD. 
For generalized t distribution, its PDF is defined as Eq.(3-1). Since 5 equals to 
d [\j{v-2)l7r (v>2), the CP values can be described as a ftinction of u, d and v, 
rL 打 ( 宇 ） , (卜 “)2 ^ 
CP/(«，J’v，L)= p(tlu,d,v)dt= ^ , ( 1 + 乂 ( 3 - 4 ) 
where L equals to 5, 10, 15mmHg as required by BHS protocol [30]. 
The selection of v was restricted to be within 3 and 30 since at distributions with v>30, 
they can be approximated by a normal distribution. With the values of CPl estimated 
from the reported MD and SD by Eq.(3-3) and (3-4)，an estimated BHS grading can be 
then obtained. 
卫,Data analysts 
To determine the degree of freedom that best matches the underlying distribution, the 
estimated BHS gradings were compared to the corresponding reported ones. Stuart-
Maxwell chi-square test [44-45] was used to quantify the agreement, and the Chi-square 
value and p-value were calculated respectively. Meanwhile, mapping charts that relate 
MD, SD and CP values are plotted under both normal distribution and the distribution 
that matches best to the real situation. 
C Jiesu/is 
The evaluation results of 40 devices were collected from literatures, where the MD, 
SD, CPs,10,15 of the error distribution and the BHS grading for each device on the 
- 2 3 -
Qiapter 3. Error Distriftution Model 
measurement of SBP and DBP were reported. The information of the devices was 
summarized in Table 3-1 [46-83]. All the devices were graded according to the version 
of BHS protocol revised in 1993 [30]. 
TABIJi； :M. m m V M IM^OUMATIOX GATIIi:Uli:» FROM PlJRLISIIli：!) 
VAIJMTIOIV KKPORTS. 
AAMI Accuracy 叫 S 
Manufacturer Model (MD±SD) 丨 ^ c c u ^ c y Source 
(Grading) 
SBP DBP SBP / DBP 
/\&D Company, ^^-25646 -1.9 士 4.9 -1.2 ± 4 . 2 A / A [46] 
Japan 
A&D Company, ua-704 -1.9 土 4.3 -1.4 土 4.0 A / A [47] 
Japan 
A&D Company, 口八_767 -0.4 土 5.4 -0.4 ± 4 . 8 A / A [48] 
Japan 
A&D Company, ub-511 4.3 士 8.7 3.7 ± 8 . 1 B / B [49] 
Japan 
t & D Company, 口八-705 0.3 土 7.7 0.3 士 8.2 A / A [50] 
Japan 
A&D Company, 丁"-2655 -1.0 士 5.2 -0.9 ± 4 . 7 A / A [51] 
Japan 」 
A&D Company, 口八-774 -1.0 土 7.1 -1.4 士 7.6 A / A [52] 
Japan 
= m p a n y , 二 。 - O . n , -2.0 . 11.0 C / C [53]* 
BpTRU； Canada BPM-100 -0.2 士 5.1 -1.4 ± 4 . 7 A / A [54] 
Dinamap … … 
Critikon 8 i00 土 7.0 A / C [55]* 
Del Mar P ， u _ 士 让。 . 3 . 0 士 n . o B / C [56]* 
Avionics, USA eter IV ‘ ‘ l ju j 
Disetronic CH-Druck/ 
Medical Systems Pressure -3.0 ± 4.0 -2.0 ± 4 . 0 A / A [57]* 
AG, Switzerland Scan ERKA 
Disetronic 
Medical Systems Profilomat -3.0 士 5.0 -1.0 ± 5_0 A / A [58]* 
AG, Switzerland 
Dixtal Medical dX2710 0.0 士 6.3 3.8 ± 6 . 2 A / B [59] 
Ltd • 
Elettronica cardiette , , 口 _ 
Trentina S.P.a., BPone 土 4.9 A / A [60] 
Italy 
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FIGIsrl OSCILL-IT 0.4 ± 5 . 3 0.1 ± 5 . 2 A / A [61]* 
Finapres Medical 
Systems,Netherl Finometer -1.8 土 6.8 0.9 ± 7 . 5 A / B [621 
ands 
GE Healthcare = = 『 - 0 . 3 士 6.9 -4.0 ± 5 . 9 A / A [63] 
... BP3BT0-
Microhfe 八 -1.6 土 7.7 -2.1 ± 6 . 3 A / A [64] 
„ 「 DIASYS 
Novacor, France ^qq 丄 。 土 8.0 0.0 ± 8 . 0 B / A [65]* 
Omron, Japan 705-CP 2.9 土 6.4 1.2 ± 5 . 8 B / A [66] 
Omron, Japan 705 IT 4.0 土 4.8 -2.1 ± 5 . 9 A / A [67] 
Omron, Japan 705 IT 0.6 士 6.0 -3.2 ± 6.6 . A / A [68] 
Omron, Japan RX-M -7.5 土 8.4 -2.5 土 12.2 D / D [69] 
OMRON 『 - 7 0 5 士 4 7 ^ ^ 土 々 。 ^ / A [70] 
o m r o n M l 1.3 士 5.3 0.5 ± 3 . 9 A / A [701 
OMRON ^ 
u I4.U Omron- ^ ^ 
二 e a ^ a r e ^ |丁 -2.0 土 7.0 -2.0 ± 6 . 0 A / A [71] 
Netherlands 
D I u ^ Tensoval® Paul Hartmann 
Ltd. duo -2.4 士 6.0 0.9 ± 6 . 3 A / A [72] 
control 
Pharma-Smart, 
Canada PS-2000 0.1 士 7.0 -0.3 ± 6 . 6 A / A [73] 
Sensacare 
Company, Hong SAA-102 0.1 土 4.6 -2.7 ± 5 2 A / A 「741 
Kong, China ^ 』 
SpaceLabs, USA 90207 -0.5 士 7.5 -0.2 ± 5 . 2 B / A [75] 
SpaceLabs, USA 90207 -1.0 ± 7.0 -3.0 ± 6 . 0 A / A [76]* 
Accutrack 
SunTech Medical er II 
Instruments (version 土 0.8 3.5 ± 0 . 9 A / B [77]* 
30/23) 
SunTech Medical …」， 一 
Instruments 二 0.0 士 7.0 -1.0 士 6.0 A / A [78] 
TensioMed Ltd, _ . , 
Hungary 土 5.3 1.0 ± 4 . 7 A / A [79] 
Terumo Co.Ltd, ES-H531-
TokyoJapan Method I 0-9 土 3.7 0.1 ± 3 . 2 A / A [80]* 
Terumo Co.Ltd, ES-H531-
TokyoJapan Method II 工‘丄 土 4.6 2.7 ± 5 . 4 A / A [80]* 
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Welch Allyn Inc. vital signs -1.0 土 5.0 -3.0 ± 4 . 0 A / A [81] 
Welch Allyn Inc. -1.0 土 4.1 -0.4 ± 6 . 1 A / A [82] 
Welch Allyn Inc. SureBP -0.9 ± 7 . 2 -2.2 ± 6 . 7 A / A [83] 
* denotes the reports using the 1990 BHS protocol. These devices are re-graded 
according to the 1993 revised BHS protocol 
Stuart-Maxwell chi-square test was conducted between the estimated grading from t 
distribution with different degrees of freedom and the reported BHS grading. The 
resulted chi-square values were plotted in Fig. 3-1. When v=3-4 for SBP and v=3-5 for 
DBP, the difference between sample distribution and hypothesized distribution was non-
significant at the level of 0.05. 
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Fig. 3-1. Chi-Square value from Stuart-Maxwell test between estimated and 
reported BHS grading under generalized t distribution wi th different degree of 
freedom. The significant level is 0.05 (Chi-Square value=7.8). 
Based on this result, Table 3-2 further compared the reported BHS grading with the 
estimated grading based on the assumption of normal distribution or t4 distribution. 
Ideally, the numbers should either lie on the diagonal of the table or around the diagonal 
symmetrically. It is apparent from Table 3-2 that t4 better described the underlying 
distribution than the normal model. Under normal distribution, the percentage of 
matched pairs between the estimated and reported grading is about a half, which result is 
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in accordance with that from Sun and Jones. When t4 distribution was applied instead, 
the percentage of matches increased to 82.5% and 80.0% for SBP and DBP respectively. 
Therefore, t4 distribution is chosen for the following study. 
TAlSLIi： 3-2. COMPAIUSOX OF THK i:STIMATi:i) AXI) Till!： UlUPOUTEl) BHS 
tiUADIiXG lJM)i:U XOKMAL DLSTIUBIJTIOX Ai\I) T4 DLSTUIBIJTIOIV. 
(a) Normal Distribution 
SBP — D B P ~ 
Reported Estimated BHS Grading Reported Estimated BHS Grading 
BHS Grading a B C D BHS Grading g q ^ 
A 18 13 2 0 A 17 12 3 0 
B 0 1 2 2 B 1 0 3 0 
C 0 0 0 1 C 0 0 0 3 
D 0 0 0 1 D 0 0 0 1 
chi-square=18.9 (p=0.0003) chi-square=17.3 {p=0.0006) 
Matches%=50.0% Matches%=45.0% 
(b) Generalized t Distribution (degree of freedom=4) 
SBP DBP 
Reported Estimated BHS Grading Reported Estimated BHS Grading 
BHS Grading A B C D BHS Grading g q ^ ~ 
A 29 4 0 0 A 27 5 0 0 
B 0 3 2 0 B 1 2 1 0 
C 0 0 0 1 C 0 0 2 1 
D 0 0 0 1 D 0 0 0 1 
chi-square=7.0 (p=0.07) chi-square=4.7 (p=0.2) 
Matches%=82.5% Matches%=80.0% 
In Fig. 3-2，3D graphs relating CP5 with MD and SD were plotted under the normal 
distribution and t4 distribution based on Eq.(3-1) and (3-4) respectively. With CP5 
equalled to the specified values in BHS grading criteria, the grades A, B and C/D were 
drawn accordingly. 
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Fig. 3-2. CPs below certain limits, as required by BHS protocol, in relation to 
mean difference and standard deviation under (a) normal distribution and (b) 
t4 distribution. 
Fig. 3-3 is the projection of the 3D plots on the plane of SD and MD. For grade A and 
B in BHS grading, satisfying the requirement of CP5 guaranteed that of CPio and CP15. 
Therefore, only CP5 were plotted. The criteria for ESH protocol and method 1, 2 in 
AAMI standard were also plotted. 
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(a) Normal Distribution 
AAMI Method 1 BHS Grade A and ESH 
7 � AAMI Method 2 j — BHS Grade B 
• • • 1 BHS Grade C 
】2 - . . :'、:〈、、；\ :、i、 ‘ 
BHS-A/ESH .BHS如 r 
qI.—.冊‘‘‘-• ' ~~^―^ ‘——^ ^ _ _ , 
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Standard Deviation (mmHg) 
(b) t4 Distribution 
AAMI Method 1 BHS Grade A and ESH 
7 � — AAMI Method 2 — i BHS Grade B 
• • • • BHS Grade C 
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bhs -a /bh \ y l ^ ^ B 
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Standard Deviation (mmHg) 
Fig. 3-3. Relationship between the AAMI, BHS and ESH evaluation systems 
under (a) normal distribution and (b) t4 distribution. 
3.3. Distribution analysis on a cuff-less device 
Jl Txj?eriment 
Testing of a cuff-less BP device on at least 85 subjects by a similar protocol 
described by the AAMI or BHS was not found in literature except the one we reported in 
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[16]. In that study, a group of 85 volunteers were enrolled, with 49 females and 36 males. 
The subjects were ranged from 18-96 years old. Amongst them, 39 subjects (46%) were 
diagnosed of hypertension. The participants' BP values at the recruitment ranged from 
82 to 176 mmHg and 40 to 84 mmHg, for SBP and DBP respectively. The subjects were 
recruited from Caritas Harold H.W. Lee Care and Attention Home and later at the 
Faculty of Engineering of The Chinese University of Hong Kong. Written consent to the 
participation was obtained from each subject. 
The study participants were introduced to the observers, who explained them with the 
eligibility requirements and specific procedures. Initials, sex, date of birth, medical 
history and taking of medicine were recorded on the case report form. A registered and 
experienced nurse was employed for providing the reference reading using a calibrated 
mercury sphygmomanometer. As was recommended by AAMI standard, the cuff 
bladder length and width was approximately 0.80 and 0.40 times the circumference of 
the upper limb, respectively. SBP and DBP measurements with the mercury 
sphygmomanometer were determined using the phase I and phase V Korotkoff sounds 
respectively. The time intervals between two measurements were no smaller than 30s to 
prevent venous congestion, and no larger than 60s to avoid increasing variability. 
Subjects were asked to relax for at least 5min to minimize any anxiety that might 
increase BP variability. All the measurements were taken when the subjects were sitting 
down in a quiet and warm circumstance. 
Before starting the measurements, the cuff-less device was calibrated for each 
individual subject on the first day of his/her participation. The first measuring trial was 
conducted within 30 min after the calibration. Each subject contributed 3 datasets, and 
each dataset consisted of: 1) BP reading measured by the nurse; and 2) 45-second 
simultaneous recording of ECG and PPG, which were obtained from the fingertips, for 
measuring BP by the cuff-less pulse transit time (PTT)-based technique [16]; and 3) 
readings obtained by an oscillometric device (OmronHEM-907, Japan), which has 
passed both AAMI standard [84] and the two phases of the international Protocol from 
ESH [85]. 
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Two other trials, once in each week and each with three datasets, were carried out 
during the subsequent two weeks. 78 out of 85 subjects participated in a follow-up 
study carried out one month after his or her last trial, where another three datasets were 
collected. Accordingly, with 78 subjects provided 12 datasets and 7 subjects provided 9 
datasets, a total of 999 datasets were collected. 
Data anafysis 
Firstly, the accuracy was assessed according to the AAMI passing criteria and BHS 
grading systems. With the assumption of normal or generalized t distribution with 
degree of freedom of four (t4 distribution), BHS grading was then estimated from the 
reported values of MD and SD, which was then compared to the reported grading. The 
estimation method was the same as the former literature study in section 3.2. 
Secondly, the probability distribution of the measuring differences between the test 
device and reference was fitted to the normal distribution and t4 distribution. Fitting 
results were illustrated by cumulative distribution plot with predicted fitting lines. 
Quantitative statistical method, Kolmogorov-Smimov (KS) test, was used to assess the 
goodness-of-fit of the hypothesized distribution. 
C ^ u / i s 
The agreement between the cuff-less device and the reference was 0.4土8.9mmHg and 
1.1 ±5.9mmHg for SBP and DBP respectively. It achieved a BHS grade B for SBP and A 
for DBP. When converting the MD土SD to BHS grading under the assumption of normal 
distribution using Eq.(3-3)，the estimated grading results were C/B. On the other hand, 
when t4 distribution was applied using Eq.(3-4), the estimated grading was the same 
with the reported ones, which was grade B/A. This result was accordant with the former 
distribution study on 40 published validation reports, and again proved the validity of t4 
distribution. 
Fig. 3-4 shows the fitting results of the estimation error for the cuff-less device to the 
normal distribution and t4 distribution. For SBP, t4 fitted the experimental data very 
well, while normal distribution had a deviation in the central part. For DBP, both 
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distributions got a deviation with respect to the experimental data and the deviations 
were in different direction. 
(a) Systolic blood pressure 
1 • iTirrTfilflBBiWtt 
j^utjgpw**"' 
。.‘• i f 
^ 0.7 - 运 
？。.6. / 
I 0.5 • i 
I 0.4 • / 
卜 / 
0.2 - 沒 
^ f f sample difference 
0.1 • ^ ^ 来 lilting 
O normal fitting 
0 tWWB^ ^^ ^^ ^^  ""* II.'^  * ‘ 
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DifTerence ( m m H g ) 
(b) Diastolic blood pressure 
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Fig. 3-4. Cumulative percentage difference from the PTT-based device wi th 
corresponding hypothesized cumulative distribution function values, normal 
distribution and t4 distribution (a) for systolic blood pressure and (b) diastolic 
blood pressure respectively. 
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Fig. 3-5 presents the statistic measure from the KS test. At v=4, the difference 
between sample distribution and the hypothesized distribution was non-significant 
(p=0.15) for SBP, but was significant for DBP (p=0.0006). 
T —e—SBP 
0 .091 - A - D B P 
r i 
f i \ 
S> 0.05 l i 
I � • • • • M i i l M H l i m 
U 0.04 - I 
0.03 -
0.021——‘ ‘——‘ ‘ ‘——‘——‘ ‘——‘ 
3 5 7 9 11 13 15 17 19 21 23 25 27 29 
degree of freedom 
Fig. 3-5. Kolmogorov-Smirnov test assessing the goodness-of-fit of the 
generalized t distribution with different degree of freedom. The significant level 
is 0.05 (Kolmogorov-Smirnov statistic= 0.043). 
3.4. Discussion 
Jl St^pjyorUng evidencefor t4 dbtrWutum 
The AAMI standard and BHS protocol are widely accepted as the standards for 
validating the accuracy of conventional cuff-based BP measuring devices. Examination 
of the statistical considerations when these standards were established revealed that both 
standards were based on the assumption that the errors were normally distributed [25-
27,30]. A literature study of the validating reports, however, revealed that this 
assumption may not be appropriate. The generalized t distribution is therefore proposed 
to re-examine the real underlying distribution [41]. 
As illustrated in Fig. 3-1，the study on 40 cuff-based devices showed that t4 was a 
better model than the normal distribution on prediction of the errors for most BP devices. 
Using this distribution, more than 80% of the BHS grading of 40 devices agree with that 
estimated from their AAMI evaluation results. An experimental study on a cuff-less 
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device also supported this conclusion, where the differences between t4 distribution and 
experiment error distribution were non-significant for estimation of SBP. 
Furthermore, as illustrated in Fig. 3-2 and Fig. 3-3’ a new mapping chart relating 
AAMI, BHS and ESH protocols was plotted for both normal distribution and t4 
distribution. The phenomenon that some devices received grade B under the BHS 
system but failed the AAMI standard is well explained; which in turn proved that the 
real underlying distribution for the BP measuring devices, regardless of whether cuff 
based or not, all approaches to the t4 distribution. 
孔 Jrnpftcatwnsfor tfie apj?fwation oft4 dbtrifutum 
This study not only provided us a statistical foundation for the future development of 
the new standard, but also suggested that existing standard for the cuff-based devices 
may need to be reviewed based on the new distribution. For example, it was introduced 
in section 2.2 that, method 2 of AAMI was designed based on the concept that a device 
is considered as acceptable if its probability of measurements with a tolerable error (i.e. 
±10mmHg) is at least 85 %. When applying this rule for a t4 distribution, the 
requirement of SD is actually 8 instead of 6.95 mmHg (as required by method 2 in 
AAMI) at MD=0. 
It shall be noted that, since there have not been any standards developed for cuff-less 
devices, we decided to study based on existing standards, even though they were 
developed for cuff-based devices. During the study of the underlying error distribution, 
we found that no matter the devices are cuff-based or cuff-less, they share a common 
kind of distribution. One of the major reasons contributed to this result could be that the 
error sources for both of them are similar. 
Nevertheless, although the t4 distribution behaved very well in the study of various 
BP devices, the real distribution for each individual device varies. For example, Fig. 3-5 
shows that t4 distribution was not the best model when portraying the error distribution 
measured by the test device. This observation also calls our attention that the new 
evaluation system may need to allow a variation of the distribution in certain degree. 
This problem is further discussed in chapter 4 when selecting the evaluation parameter. 
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3.5. Section Summary 
In summary, this study focused on the statistical aspect of establishing standard to 
assess the accuracy of cuff-less BP measuring devices, based on the experience of 
existing standards for evaluating conventional cuff-based ones. The results of our study 
on the validation reports of various cuff-based devices and an experimental study on a 
cuff-less device showed that the t4 distribution is better than the normal distribution in 
portraying the underlying error distribution of both kinds of devices. We verified the 
model using evaluation results from 40 devices, of which more than 80% of the AAMI 
and BHS reporting results were in agreement, as compared to 50% if the original normal 
model was used. We further tested a cuff-less device on 85 subjects for 999 datasets and 
found that the differences between the proposed distribution and that of the device was 
non-significant for SBP measurements (Kolmogorov-Smimov=0.036, p=0.15). 
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Chapter 4. Evaluation Scale to Assess the 
Accuracy 
Currently, the validating and reporting approaches for the cuff-less techniques or 
devices vary largely from study to study in terms of the evaluation protocol, the 
accuracy measures and the graphical plots, as summarised in Table 4-1. As a result, it is 
difficult to compare the accuracy among devices. Therefore, we intend to propose some 
accuracy parameters that allow a fair representation of the device accuracy. 
t a b l k 4-1. lumm oiv s t u d i k s o r c u f f - l i : s s d k v i c k s . 
Source accuracy index* statistical plot** test reference 
[86] MD, L95% B-A plot intra-arterial 
[87] L95%, R-value / intra-arterial 
[88] RMSD, MD / intra-arterial 
B-A plot, probability intra-arterial and mercury 
[89] MD'SD, L95% histogram sphygmomanometer 
[90] MD, SD / BM3 Patient Monitoring 
[91] MD, SD / BM3 Patient Monitoring 
„ , , mercury sphygmomanometer 
[16] MD, SD, L95% B-A plot and oscillometric device 
[92] MD, SD / oscillometric device 
[93] r-value, MD^SD / fmometer 
… ， 1 , tonometer and oscillometric 
[94] / B-A plot, tracing plot device 
[95] MD, SD / finometer 
[96] RMSD correlation plot oscillometric device 
[97] L 9 5 % M a S D , / intra-arterial 
CPs,10,15 
[98] p-value / finometer 
[99] SD / oscillometric device 
[100] r-value correlation plot finometer 
* RMSD: root mean square difference; MD: mean difference; 
p-value: result from student-t test; L95%: 95% limits of agreement; 
r-value: correlation coefficient; 
CPs,10,15: cumulative percentages falling within 5,10,15 mmHg; 
B-A plot: Bland-Altman plot. 
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4.1. Considerations for parameter selection 
Jl Outfyin^ errors ancCsystem Bias 
The benefit of using MD or SD is that each individual measuring difference between 
test device and reference measurement has to contribute to the final accuracy decision. 
These parameters may however be unduly influenced by occasional outlying values [26]. 
On the contrary, for a protocol that judges by the percentages of differences falling in 
certain limits, it only takes care of the number of differences but not the value of them. 
Therefore, the CP values will be less influenced by the outliers but can be misleading 
when there are large systematic differences [26]. It must be noted that the consequences 
of a systematic bias should never be underestimated for it has been shown that an 
overestimation of DBP by 5 mmHg would increase the number of hypertensives by as 
much as 132% or more [101]. 
% Accuracy at different levels of BCbocCjrressure 
In the AAMI analysis, it was assumed that the distribution of differences did not vary 
in over the range of real BP. This is not true in all circumstances. Bland-Altman plot was 
introduced by AAMI and utilized by other protocols (i.e., BHS and ESH protocols) to 
provide a clear view of the measuring agreement between test device and reference at 
different levels of BP. As shown by the Bland-Altman plots from many validation 
reports, measurement errors often increase with BP [36,102]. During a study of six 
ambulatory devices, when the data were analysed according to the levels of pressure for 
low, medium and high pressure ranges, as defined by BHS protocol, all six devices held 
their overall grading, or improved them slightly in the low and medium pressure ranges 
but less accurate in the high pressure range [36]. 
The AAMI standard declared that analyzing approaches utilized by existing protocols 
cannot effectively portray this kind of complex distributions, and in such circumstances, 
exiting protocols maybe not applicable anymore [17]. Braam and Thien [102] believed 
that the phenomenon was due to the increment of BP variability with BP. For this kind 
of error distribution, applying a constant accuracy limit across the whole range of BP is 
tantamount to tolerating larger measurement errors at the low BP and underestimating 
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the accuracy at high BP. The situation is more complex for cuff-less devices for that the 
accuracy of the device itself may vary with BP level depending on the pressure point 
that is chosen for calibration. 
To solve this problem, the BHS protocol recommended analyzing the accuracy not 
only for the overall pressure range but also in three defined BP ranges [30]. Nevertheless, 
they also emphasized that data from this analysis are provided only to indicate possible 
trends in accuracy of the test device, and no restriction was laid down for this part of 
accuracy assessment [30]. We however would like to investigate parameters that can 
quantify the accuracy of a device at different levels of BP. 
4.2. Description of selected parameters 
Taking the above considerations into account, and some other pre-considerations as 
computing expense, understandability and facility for decision making, we selected three 
parameters for the study: mean absolute difference (MAD), root mean square difference 
(RMSD) and mean absolute percentage difference (MAPD). 
Their definitions are described as follows: 
MAD = (X"=JA->', | ) /«' (4-1) 
RMSD = (Pi - y i a n d (4-2) 
MAPD = 00(p丨 一 乂.)/ x I ) /" ’ (4-3) 
where is the readings from test device, yi is from the reference measurements and n is 
the data size. 
4.3. Theoretical relationship between "new" and "old" 
parameters 
The relationships between the selected "new" parameters with those "old" parameters 
used in the current standards, i.e., MD, SD and CP, are established based on t4 
distribution model. 
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Ji Matfiematicafrelatwnsfiip 
Firstly, under generalized t distribution, MAD was related to MD (m), SD {d) and 
degree of freedom (v) by integrating the its PDF as defined as Eq.(3-1) [103]. According 
to the study by Psarakis and Panaretos [104], the random variable W= Itl, which termed 
as the folded t variable, has the expected value and variance of: 
厂 r d , 
E { W ) = 2 , - — — 2 _ (v>i) 'and (4-4) 
4 f • 
var(\y) = — ^ ——^~ (v > 2)' (4-5) 
v - 2 ; r ( v - l ) 2 厂 ( I ) 
V 2 y 
where r ( . ) denotes the Gamma function. 
MAD can be then represented by the following equation [103]: 
？-ir 广 + 1 � 
MAD= \t\-p(t\u,s,v)-dt= \t\ — ) � d t 
= 2sr x-f{x)dx+\u\-Pr\-—<x< — 山"I"�. s s 
「 ( V + 1 
= + I 丄))， (4-6) 
2 s 
where is the scale, and equals to d •柳一 2)/n (v>2) and Pr[t < tO] is the cumulative 
distribution function. 
Secondly, RMSD is related to MD (m) and SD (d) by 
regardless of the degree of freedom of the distribution. 
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Based on the above equations, mapping charts were plotted to relate MAD and 
RMSD with the AAMI, BHS and ESH evaluation criteria under t4 distribution. Since 
MAPD uses relative difference (pryd/yi instead of absolute difference (pryi), it is not 
displayed on the map. 
卫.Ma_pjHng relaticnsfitp 
As shown in Fig. 4-1，MAD and RMSD were plotted against MD and SD according 
to Eq.(4-6) and (4-7). 
(a) Mean absolute difference (MAD) 
AAMr Method 1 BHS Grade A aiicl ESH 
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(b) Root mean square difference (RMSD) 
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Fig. 4-1. (a) Mean absolute difference and (b) root mean square difference as a 
function of mean difference and standard deviation under t4 distribution. The 
red lines are MAD or RMSD with values equal to 5, 6 and 7 mmHg from inter to 
outer. Passing criteria for AAMI and ESH protocols, and grading criteria for BHS 
protocol are also plotted. 
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This figure was on the basis of Fig. 3.3 (b), which presents the relationship between 
criteria of current protocols under t4 distribution. For grades A and B in BHS protocol, 
satisfying the requirement of CP5 guaranteed that of CPio and CP15. Therefore, only CP5 
were plotted. While for grade C, CP5 and CP15 together determined the grading results. 
4.4. Assessment of accuracy at increasing blood pressure levels 
As mentioned in section 4.1, a tendency was noted for accuracy to deteriorate with 
increasing level of BP from several studies. Therefore, in this section, we will 
investigate parameters that can quantify the accuracy of devices at different levels of BP. 
Jl Data transformation 
It is suggested by Bland and Altman [105] that, in the circumstance that the deviation 
of the differences increases as the measurement increases, log transformation of the 
original data might be useful. Ideally, if the measurement error is proportional to the 
pressure level, a logarithmic transformation would yield a Bland-Altman plot that 
present a uniform distribution across the whole range of BP. We can then apply the 
traditional ways of analysis to the transformed data. 
A more transparent way of doing this transformation is working directly with the 
ratios. Instead of taking logs and calculating differences we can simply calculate the 
ratio of the difference over the reference for each pair of measurements. 
According to the above discussion, unit-less parameters such as MAPD, may have the 
great potential to quantify the performance of devices with increasing differences as BP 
increases. As seen from Eq.(4-8), by calculating the ratio of differences to the reference 
BP, it is similar to performing a logarithmic transformation and thus reducing the 
dependency of the differences with BP. 
In [(p, . — ) / ] 二 In ( p . - y . ) - l n ( 兄 . ) . (4-8) 
% IWHmentafstiuCy 
The data collected from the experiment described in section 3.3 was employed, where 
999 datasets from 85 subjects were collected, with each datasets consisted of three 
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readings measured by an registered nurse, a cuff-less PTT-based technique and an 
commercialized oscillometric device respectively. 
Fig. 4-2 shows the scatter plots of the differences between cuff-less device and 
reference measurement vs. reference measurement; and the ratio of differences (or 
relative difference) and reference vs. reference measurement. Fig. 4-3 shows the results 
for oscillometric device in the same way. 
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Fig. 4-2. Scatter plots for the cuff-less device with (a) the measuring differences 
and reference measurement; and (b) relative differences and the reference 
measurement. 
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Fig. 4-3. Scatter plots for the oscillometric device with (a) the measuring 
differences and reference measurement; and (b) relative differences and the 
reference measurement. 
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The calculated MAPD for cuff-less device and the oscillometric device were 5.6% 
and 4.7% respectively. At the 95% limits of agreement, the cuff-less device differed 
from the reference by 15.1% below to 14.2% above; the oscillometric device differed 
from the reference by 13.1% below to 8.8% above. 
4.5. Discussion and application 
Ji Parameter selection 
As illustrated in Fig. 4-1，MAD was related to the AAMI and BHS protocols under 
the new distribution. A similar boundary shape between MAD and the grading of BHS 
as well as the passing criteria of method 2 of AAMI, makes it a prominent new indicator 
for assessing the device accuracy by itself. The idea of evaluating the devices by a single 
accuracy scale may facilitate the direct comparison between devices. 
Moreover, in the discussion part of chapter 3，it was mentioned that although the t4 
distribution behaved very well in the study of various BP devices, the real distribution 
for each individual device varied. This observation also calls our attention that the new 
evaluation system may need to allow a variation of the distribution in certain degree. In 
other words, this system should have an accuracy limit that "automatically adjusted" to 
cater for slightly different distributions. The BHS grading system performs well in this 
aspect for that it gives a changing requirement to t distributions of different degrees of 
freedom. MAD also has this property [106], for as shown in Fig. 4-4’ the changing trend 
of MAD is similar to that of CPs from BHS. 
It is desirable that the selected parameter can appropriately include each measurement 
error in the assessment, and justly take care of the outlying errors and system bias. With 
regards to this issue, MAD is preferred as it weighs all the differences equally as 
opposed to RMSD and SD, which weighs the larger differences heavier than the smaller 
ones. 
Furthermore, as mentioned previously, it is unfair to apply a constant accuracy limit 
to measurements at both the low and high levels of BP, since the variability may 
increase at high BP and larger intrinsic "errors" were induced inevitability by sequential 
measurements [102,107]. In such circumstances, data transformation may be helpllil. 
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Fig. 4-4. Relationships between degree of freedom wi th (a) cumulative 
percentage of differences within 5 mmHg (CPs) and (b) mean absolute 
difference (MAD), wi th changing standard deviations (SD). The mean difference 
is set to zero. 
As shown in Fig. 4-2 (a), the cuff-less device presented an apparent relationship 
between the difference and reference measurement; the differences increased as the BP 
increasing. For the cuff-based oscillometric device in Fig. 4-3 (a), a similar trend was 
observed, but the differences extended less apart as compared to the cuff-less device. 
These results proved that conventional ways of evaluating the SD would give a limit of 
agreement wider apart than necessary for small BP, and rather narrower than they should 
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be for larger BP. Moreover, the extreme errors lying at the larger BP end would greatly 
influence the decision of accuracy in such situation. 
As shown in Fig. 4-2 (b) and Fig. 4-3 (b), ratio transformation was highly successful 
in terms of reducing unwanted dependency described above. The transformed 
differences were much less dependent on the reference measurement. Since the extreme 
errors gathered closer to the mean axis, the influence of these outlying errors on the 
evaluation process was reduced correspondingly but never ignored. 
Therefore, MAPD have the great potential to be used for quantifying the accuracy. 
By using the relative difference as the calculation unit, it successfully reduces the 
dependency of the measurement errors with BP [108]. 
Moreover, this study also provided some implecations to the underlying error 
distribution. In chapter 3，we already concluded that the error distribution of the BP 
measuring device more resembled a t4 distribution rather than normal distribution, 
which represented with a sharper peak and longer tails. This shape of distribuation may 
correlate to the dependency of error with BP level, since the longer tails could be the 
result of more etreme errors that mostly gathered at the higher BP end than they were 
expected. 
Samjjik size 
Admittedly, the larger the sample the better in its estimation to the accuracy measure; 
however, the increased sample size causes unnecessary waste of time and resource, and 
also bring inconvenience to participating subjects. 
In AAMI and BHS protocols, they require to include at least 85 subjects, each of 
whom contributes 3 measuring datasets. This requirement is determined from the 
statistical relationship between the minimum sample size and the desired confidence 
interval to be achieved [26]. The large number of subjects makes the protocols hard to 
fulfil and few centres are willing to undertake [29]. ESH working group examined and 
analyzed the data from published validation studies that followed the AAMI and BHS 
protocols, and claimed to reduce the sample size to 33 while without losing the merits of 
the earlier protocols [29]. However, this reduction in sample size accompanied by a 
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significant reduction in statistical power and increased the risk of failing to reject an 
inaccurate device [32]. 
Based on the previous study on parameter selection, this study determines the sample 
size as the least number of subjects that is needed to yield confidence intervals having 
the desired precision of MAD. From the study of Bonett and Seier [109], when the data 
is symmetrically distributed around zero (mean, median=0), the sample size n at 100(1-
a) % confidence interval of MAD is, 
" 二 4 ( f - l ) ( Z 议 / 2 / l n (幼 ) 2 (4-9) 
where y=a^ A^ z is MAD, co is the desired ratio of the upper to lower endpoints of r; f 
is the planning value of 7. 
Assuming that the data follows a t4 distribution, when setting the desired value of 
MAD to 6.0 mmHg, a will be 8.49 mmHg and f will equal to 2. The sample size is then 
at least 136 with the 95% confidence interval for a true MAD with value of 5.0 to 7.0 
mmHg. Therefore, if each subject contributes 3 datasets, the desired number of subjects 
is at least 45. 
C Accuracy criteria 
To provide a general idea about the accuracy level of the test devices represented by 
MAD, a table was provided here with the approximately equivalent results reported by 
method 1 of AAMI standard and grading of BHS protocol. Table 4-2 was built up on the 
basis that the real underlying distribution of the measurement difference followed a t4 
distribution. 
From Table 4-2，MAD at 5-6 mmHg may be acceptable and accurate enough to be 
recommended for clinical routine use. However, it should be noted that at this stage of 
the standard development, this accuracy limit is only recommended temporally. 
Modification would be necessary when a reasonable large amount of devices are 
validated according to this standard and sufficient data are provided. 
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TABLE 4-2. MAI) ACCIJUACY LKVEL WITH OOMPMILSOIV TO THE AAMI AM) BUS 
EVALIJATIOX SYSTEMS. 
MAD (mmHg) Method 1 of AAMI BHS 
<4 pass Grade A 
4-5 pass mostly Grade A, 
few Grade B 
5-6 pass or fail mostly Grade B, 
few Grade A, 
extremely few Grade C/D 
6-7 mostly fail； mostly Grade C, 
less pass few Grade B and D 
^ ^ worse than Grade C 
4.6. Section summary 
In summary, based on both the theoretical and experimental studies, MAD or MAPD 
are recommended as continuous scale to assess the accuracy of cuff-less devices for their 
own distinctive advantages. MAD properly takes into account all the datasets; and based 
on the proposed distribution model, a map was developed to relate MAD with the 
criteria in AAMI, BHS and ESH protocols; in addition, it is shown to be flexible to 
changes of error distributions. On the other hand, MAPD is prominent at evaluating 
devices that have errors increase with BP, which is an issue has not been ftilly explored 
in existing standards. Also based on this study, the desired number of subjects is 
determined to be at least 45. With each of them contributes 3 datasets, MAD will be at 
95% confidence intervals of 5 to 7 mmHg when the calculated value equals to 6 mmHg. 
Moreover, based on the mathematical relationship between MAD with the current 
evaluation systems, a device with MAD of 5-6 mmHg may be considered as accurate 
enough to be used for clinical diagnosis. 
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Chapter 5. Feature Oriented Protocol Design 
Based on different principles from that of the conventional cuff-based devices, the 
cuff-less BP measurement approaches often require an individual calibration procedure 
to determine the subject-dependent coefficients. Since this procedure is crucial to ensure 
the device accuracy, special validation protocol should be designed to assess its 
efficiency. Therefore, this study is motivated accordingly. 
5.1. Rationale of accuracy assessment with BP change 
Since the physiological parameters in the estimation model of cuff-less BP devices 
are often subject-dependent, a calibration procedure is required for each individual user 
before measurement. The calibration is important for that the estimation accuracy is 
quite dependent on its efficiency. As BP varies with time, its long-term variability may 
be as large as 14.7 mmHg for SBP and 10.8 mmHg for DBP in severe hypertensives 
[107]. Devices that claim to measure continuous BP should be assessed if they are able 
to trace and record this variation accurately. 
Existing evaluation protocols require the subjects to seat quietly for three 
measurements in order to reduce the effect of BP variation on the assessment of 
accuracy of devices. These protocols may suffice in the evaluation of traditional cuff-
based device, but not the cuff-less ones. To evaluate whether a device has been properly 
calibrated, the evaluation protocol should require the test set to consist of BP data that 
distribute widely around the BP measured at calibration. 
This study proposed a validating protocol for assessing devices that aim to measure 
continuous BP or track BP variations. In the following sections, the rationale of this 
protocol is explained and supported by two sets of experimental data. For illustration 
purposes, only the estimation results of SBP were provided. 
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5.2. Experiment one 
BP data was collected from a study conducted on 28 healthy subjects aged 23-37 
years [110]. All measurements were taken in a sitting position. Individual calibration 
was performed using a cuff BP and a hydrostatic method [111]. 
3 measurements were made by the cuff-less approach, where the first measurements 
were used for calibration objective and not included for accuracy assessment. Before and 
after each measurement, cuff BP were taken and their average was used as the reference. 
Each cuff BP consisted of a reading reported by an experienced registered nurse using a 
mercury sphygmomanometer and a reading simultaneously obtained from a validated 
oscillometric device (Omron HEM-907; passed both the AAMI and ESH protocols) that 
was connected to the mercury column by a Y-tube. 
Subjects were then directed to run on a treadmill for three minutes. Another 3 sets of 
data were measured after exercise. After excluding 1 dataset where error was reported in 
obtaining the reference BP, a total of 139 datasets were used for the following 
assessment. 
5.3. Experiment two 
The data collected from the experiment described in section 3.3 was employed [16]. 
These data were captured 6.4 土 2.5 weeks after the calibration for each subject, to allow 
certain range of BP variation. Each subject contributed four trials of measurements 
collected approximately 1, 2, 6 weeks after the time of calibration. As a result, 999 
datasets from 85 subjects were collected, with each datasets consisted of three readings 
measured by an registered nurse, a cuff-less PTT-based technique and an 
commercialized oscillometric device respectively. The readings by the nurse were used 
as the reference in this study. 
5.4. Data analysis 
The measuring accuracy was analyzed by MAD, MAPD, MD, SD, as well as the 
CPs,10,15 between the estimated and reference BP. The analysis was breakdown into three 
levels: first for all datasets, then on the subset of data collected from different trials 
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respectively and finally divide all the datasets into 3 groups according to the BP changes 
for each dataset. BP changes of each dataset were calculated as the differences between 
the reference BP of each dataset and the cuff BP measured at calibration for the same 
subject. The level of BP change for a certain group of data was represented by their 
mean absolute value. Since the sample size for experiment one is not large enough as 
required by BHS protocol, the grading was only provided for the second study. 
5.5. Results 
Ji Txjjertment one 
The results were summarized in Table 5-1. SBP changes of the first subset of data 
were generally small with averaged absolute BP changes of 2.1 mmHg. After including 
the datasets recorded after exercise, the mean absolute BP changes of all datasets 
increased to 12.6 mmHg. 
TABLK 5-1. DKVICK ACClJttilCY KHPOKT FOR SYSTOLIC BLOOD PUESSUKIi： 
MEASUKKMIillVT (IHXPIilKIMIilXTOM^ X=13») 
BP Changes MAD MAPD MD SD CPs CPio CPis 
(mmHg) (mmHg) (%) (mmHg) (mmHg) (%) (%) (。/。） 
Overall (N=139) “ 
12. 6 6.8 5.7 -2.3 9.0 49.6 74.8 88.5 
Before or after exercise 
Before Exercise (N=56) 
2.1 2.9 2.8 0.5 3.9 82.1 98.2 100.0 
After Exercise (N=83) 
19. 7 9.4 7.6 -4.2 10.8 27.7 59.0 80.7 
Accuracy at different BP change levels 
0-15 mmHg (N=88) 
4.8 4.4 4.0 0.2 6.0 65.9 92.0 97.7 
15-30 (N=36) 
21.8 9.8 8.0 -3.4 11.2 22.2 50.0 80.6 
>30 (N=15) 
36.6 14.0 9.8 -14.0 8.3 20.0 33.3 53.3 
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Fig. 5-1 shows the Bland-Altman plot of the estimation results. Fig. 5-2 shows the 
distribution of BP changes of all datasets. Fig. 5-3 shows the scatter plot of the 
measuring differences vs. BP changes with datasets collected before or after exercise 
under the same scaling. Fig. 5-4 shows the scatter plot of the measuring differences vs. 
BP changes with all the collected datasets. 
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Fig. 5-1. Scatter plot of average blood pressure from test device and reference 
measurements versus the differences of them (N=139). 
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(a) before exercise (N=56) (b) after exercise (N=83) 
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Fig. 5-4. Scatter plot of blood pressure change as compared to the calibration 
point versus the measuring difference (N=139). 
jK I邓eriment two 
The results were summarized in Table 5-2 and Table 5-3，for cuff-less device and 
oscillometric device respectively. To include the effect of intra-subject variability, the 
accuracy was analyzed using all the datasets instead of averaging the data for each 
subject. BP changes of the first trial of data were generally small with averaged absolute 
BP changes of 3.9 mmHg. After including the datasets recorded over a period over one 
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month for each subject, owing to BP variation, the mean absolute BP changes of all 
datasets increased to 7.7 mmHg. 
To provide a clearer view of the result, Fig. 5-5 and Fig. 5-6 show the scatter plots of 
the measuring differences for cuff-less device vs. BP changes for data collected from 
different trials and from all the trials. Fig. 5-7 and Fig. 5-8 plotted the results for 
oscillometric device. The distributions of BP changes for the corresponding subsets of 
data were provided as well. 
TABMS 5-2. DKVICK ACClJttilCY UEPORT FOR SYSTOLIC B U ) 0 » PRlHSSlIKli： 
MMSlJUKMKiYr (liiXPlillUMIiiXT TWO, X=»})9, CIJFF-IJJSS l)l<:VICIi：) 
BP Change MAD MAPD MD SD CPs CPio CP15 
(mmHg) (mmHg) (%) (mmHg) (mmHg) (%) (%) (%) Grading 
Overall (N=999) 
7.7 7.1 5.6 -1.0 9.5 47.1 77.1 88.6 C 
Accuracy for different trials 
Trial 1 (N=255) 
3.9 4.8 3.9 -0.5 6.5 63.1 89.4 96.5 A 
Trial 2 (N=255) 
9.3 7.7 5.9 -2.2 10.7 48.6 74.5 86.3 C 
Trial 3 (N=255) 
8.4 5.8 6.2 -3.2 6.8 58.8 84.7 95.7 B 
Trial 4 (N=234) 
9 3 8.1 6.7 1.1 10.4 38.5 71.4 82.5 D 
Accuracy at different BP change levels 
0-15 mmHg (N=868) 
5.2 5.6 4.6 -0.7 7.2 53.0 85.7 95.4 B 
15-30 mmHg(N=105) 
20.6 14.1 10.7 -1.5 15.4 10.5 24.8 54.3 D 
>30 mmHg (N=26) 
40.2 27.2 18.4 -8.8 27.3 0.0 0.0 0.0 D 
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TABLE 5-3. DKVICK ACCURACY UliiPOllT FOtt SYSTOLIC BLOOD PUILSSIJUE 
MIHASmililMKlVT (IHXPlillUMliilVT TWO, IV=9»», OSCILLOMETRIC DlilVICIi：) 
BP Change MAD MAPD MD SD CP5 CPio CP15 
(mmHg) (mmHg) (%) (mmHg) (mmHg) (%) (%) (%) Grading 
Overall (N=999) 
7.7 5.8 4.7 -2.8 7.2 56.7 86.1 95.6 B 
Accuracy for different trials 
Trial 1 (N=255) 
3.9 5.6 4.5 -2.6 6.7 58.8- 87.1 95.3 B 
Trial 2 (N=255) 
9.3 5.8 4.6 -2.9 6.6 54.1 86.3 95.3 B 
Trial 3 (N=255) 
8.4 5.8 4.8 -3.2 6.8 58.8 84.7 95.7 B 
Trial 4 (N=234) 
93 5.9 4.8 -2.5 7.0 55.1 86.8 96.6 B 
Accuracy at different BP change levels 
0-15 mmHg (N=868) 
5.2 5.7 4.7 -2.9 7.3 57.0 87.1 96.1 B 
15-30 mmHg (N=105) 
20.6 6.3 4.7 -2.3 7.7 53.3 81.0 93.3 B 
>30 mmHg (N=26) 
40.2 7.1 4.6 -3.5 8.6 57.7 73.1 88.5 C 
(a) Cuff-less Device (Trial 1, N=255) 
30 -1 
u 一 140 -1 
c I 20 - • • • • 
S 1 • 120 - • 
丨;"'丨丨 L 
•5 至 • • 腳 X- — — 4 0 • • • 
11-20-
S 劣-30 -I 1 —I 1 1 1 1 T 1 0 " I ~ ‘ ~ “ ~ 鬥 ~ I ~ I ~ m ~ I ~ 
-40 -30 -20 -10 0 10 20 30 40 - 4 0 - 3 5 - 3 0 - 2 5 - 2 0 - 1 5 - 1 0 -5 0 5 10 15 20 25 30 35 40 
Blood Pressure Change from Calibration Point (mrnHg) Blood Pressure Changes from Calibration Point (mmHg) 
〜54〜 
Chapter 5. Protocol Design 
(b) Cuff-less Device (Trial 1, N=255) 
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(c) Cuff-less Device (Trial 3, N=255) 
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(d) Cuff-less Device (Trial 4, N=234) 
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Fig. 5-5. Scatter plots of blood pressure change as compared to the calibration 
point versus the measuring difference between readings from cuff-less device 
and the nurse; and the corresponding histogram of blood pressure changes 
from the calibration point, (a)-(d) show the results for different experimental 
trials. 
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Fig. 5-6. Scatter plots of blood pressure change as compared to the calibration 
point versus the measuring difference between readings from cuff-less device 
and the nurse; and the corresponding histogram of blood pressure changes for 
the data collected from all the trials (N=999). 
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(c) Oscillometric Device (Trial 3, N=255) 
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Fig. 5-7. Scatter plots of blood pressure change as compared to the calibration 
point versus the measuring difference between readings f rom oscillometric 
device and the nurse; and the corresponding histogram of blood pressure 
changes, (a) - (d) show the results for different experimental trials. 
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Fig. 5-8. Scatter plot of blood pressure change as compared to the calibration 
point versus the measuring difference between readings f rom oscillometric 
device and the nurse; and the corresponding histogram of blood pressure 
changes for data collected from all the trials (N=999). 
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5.6. Discussion 
Ji difference Between cuff'-less ancCcuff-BasecCdevices 
For the cuff-less devices, the results of the "before exercise" trial in experiment one 
and the first trial in experiment two, show a high estimation accuracy; while for the 
"after exercise" trial in experiment one and later trials in experiment two, the accuracies 
decreased significantly. In other words, the accuracy increased if the data were collected 
right after the calibration, since the devices were calibrated only once at the beginning of 
the experiment. This phenomenon is distinctive for cuff-less device, since it was shown 
from Table 5-3 that, the performance of the cuff-based oscillometric device did not 
change between trials. 
The difference between cuff-less and cuff-based devices may result from the 
calibration procedure and the variation of BP from the calibration point. To support this 
argument, the subsets of data at different BP change levels were analyzed separately. 
From both Fig. 5-4 and Fig. 5-7, it was apparent that the estimated BP deviated further 
away from the reference for larger changes of BP from the calibration point. Around the 
calibration point, i.e. when change of BP is approximately zero, the measuring 
differences were small. As the change of BP increased, the differences deviated away 
from the central line. While in Fig. 5-8, for the oscillometric device, the measurement 
difference distributed uniformly across the whole range of BP changes. Nevertheless, it 
is unfair to conclude that the oscillometric device is superior to the cuff-less device, 
since the accuracy of the cuff-less device was much higher when BP change was small. 
% Correlation Between accuracy amf O/bocfpressure cfianges 
In study one, for the 56 datasets that were measured after calibration, the MAD 
between the test approach and reference BP was only 2.1 mmHg, which is significantly 
smaller than the MAD reported for the 83 datasets collected after exercise (MAD=9.8 
mmHg). Nevertheless, it is unfair to directly compare the two numbers and conclude 
that the cuff-less approach performs better in one condition. The discrepancy in the 
value of the parameters is in fact resulted from the different distribution of BP changes. 
This demonstrates the importance of setting a requirement in the validating protocol for 
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the cuff-less devices on the distribution of BP changes in order that the reported 
estimation differences can be compared from one study to another. 
Similarly in study two, since the experiment was conducted over a period across one 
month, the BP varied even without exercise. It is shown that the estimation accuracy for 
cuff-less devices is quite dependent on the changes of BP from the calibration point. 
According to the AAMI and BHS protocols, the data collected from trial 1 is enough to 
qualify the accuracy of a device. The accuracy may pass AAMI and achieve grade A for 
BHS when only the datasets collected on the first day were used. However, the 
requirements of AAMI and BHS protocol are based on the assumption that the accuracy 
performance kept constant with BP changes. According to our study, this assumption is 
only true for the cuff-based devices, whose accuracies are independent from the BP 
changes, as seen from Table 5-3 and Fig. 5-8. While for cuff-less devices, due to the 
need of individual calibration for the physiological parameter, the accuracy could be 
much higher when the measurement was conducted within a certain range from the 
calibration. This can be shown more apparently when analyzing the data with similar BP 
changes from the calibration point. For all the accuracy measures, they all tend to be 
more accurate with the decreasing of BP changes. 
C Inducement ofBibocfpressure cfian^e 
According to the above discussion, it is necessary to assess the accuracy of cuff-less 
devices within a certain rang of BP changes. The amount of the BP changes must be 
required in the protocol, so that different devices can be compared. The required 
percentage of samples suggested at each interval of BP changes was presented in Table 
5-4. 
This table of requirement suggested that the evaluation of the cuff-less devices shall 
take into account both the distribution of BP changes and the analysis at different ranges 
of BP changes. Assuming that 45 subjects are recruited to contribute a total of 135 
datasets, the number of datasets that is required for each range is also included in the 
table. 
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TABLI： 5-4. IXDIJCKMKNT OF KLOOl) PRIHSSUUli： CIIAMili lS ‘ 
Changes of BP from the Point of Calibration (mmHg) 
SBP -30 - -15 - 1 5 - 0 0 - 1 5 1 5 - 3 0 
DBP - 2 0 - - 1 0 - 1 0 - 0 0 - 1 0 1 0 - 2 0 
Required Samples 25% (33) 25% (33) 25% (33) 25% (33) 
a Blood Pressure change refers to the reference reading measured by the observers 
minus the value at the calibration point. 
V, Otfierfactors affect tHe accuracy 
This study focused on the required distribution of induced BP changes, the method 
that to be used to achieve this goal is not restricted. In the future, the question that 
whether the mechanism of inducing BP variation will influence the accuracy evaluation 
results should be addressed. 
Moreover, the variation of BP from the calibration point may not be the only reason 
contributes to the deviation of accuracy performance for the cuff-less device. In Table 
5-2, it is shown that, although trial 2 and 4 share the same value of mean absolute BP 
changes, their accuracy results differed. Other factors, such as the calibration frequency, 
will also affect the accuracy. 
It was also found that the estimation difference were similar regardless of whether 
data were collected 1, 2 or 6 weeks(s) after the calibration. Therefore, it might be 
unnecessary to have the device assessed too many times after the first time of calibration. 
It is thus recommended to evaluate the device twice within the period between two 
consecutive calibration points. If the results of the two evaluation tests well agree with 
each other, the device can claim to be calibrated frequent enough to have a consistent 
measuring accuracy. 
In addition, it was noticed from Table 5-3 that the performance of the oscillometric 
device kept generally consistent, except for the group with BP changes larger than 
30mmHg. This group of data was further examined and it was found that the mean value 
of their reference SBP was as high as 149 mmHg. This diminution of accuracy may due 
to the fact that the BP variation increases at increasing levels of BP, as was discussed 
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previously in chapter 3. This phenomenon again reminds us that measurements near the 
extremes of the pressure range are too much unstable; when sequential measurements 
are utilized for device assessment, those subjects with extremely high pressure shall be 
carefully recruited. Otherwise, underestimation of the accuracy may occur. 
5.7. Section summary 
This chapter proposes one of the unique requirements in the validation protocol for 
assessing wearable cuff-less BP measuring devices. In this study, we used data from two 
experiments: one carried out on 28 subjects with a total of 139 sets of BP measurements 
with or without exercise, another one carried out on 85 subjects with a total of 999 sets 
of measurements collected over one month period of time. These two examples showed 
that, owing to the different kind of technique that is utilized in estimation where 
calibration is often required for the cuff-less devices, those devices shall be evaluated 
with a wide range of BP change from the calibration point. 
Generally, there are a few points worth further mentioning concerning this study: 1) 
the two examples showed that breakdown of the performance evaluation of cuff-less 
devices according to the change of BP from the point of calibration is crucial for 
understanding and interpreting the overall accuracy of the device; 2) the procedure with 
BP change inducement shall be designed into the validation protocol and the distribution 
of the BP change shall be regulated; 3) the protocol shall also cover a wide enough 
period of time, in order to assess whether the calibration of the device ages as well as it 
has claimed. 
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Chapter 6. Proposal for the Evaluation of 
Wearable Cuff-less Devices 
A standardized and efficient standard for wearable cuff-less BP measuring devices 
will not only regulate the potential market of such devices, but also provide purchasers 
with reliable information in comparing and choosing their prospective products. More 
importantly, the standard will greatly advance the development of the cuff-less devices, 
and popularize their application in the field of self and ambulatory BP monitoring. 
Because of the lack of experienced data with similar validation protocols on the 
evaluation of such devices, it is difficult to quantify and compare the accuracy of them. 
It is necessary to propose an evaluation standard and encourage the device developers to 
have their products evaluated and reported on a uniform basis. Therefore, based on the 
previous study and the experience from the current standards for cuff-based devices, this 
chapter intends to propose an integrated evaluation protocol including validation 
procedure and reporting approaches. 
6.1. Scope 
The scope of this protocol is the wearable cuff-less BP measuring devices. The 
protocol is independent of the form of the device or the vehicle the device is attached to 
or embedded in. The protocol is applicable to all types of wearable BP measurement 
devices that have different modes of operation (e.g. to measure short-term, long-term, 
snapshot, continuous, beat(s)-to-beat(s) BP or BP variability). This protocol is, however, 
limited to the evaluation of devices that does not use a cuff during measurement and 
does not cover evaluation of all sphygmomanometers that are used with an occluding or 
inflatable cuff for the indirect determination of BP on the upper arm or wrist. 
6.2. Purpose 
There is currently no defined, independent standard for wearable cuff-less BP 
measuring devices, which have drawn growing interest in recent years. Existing 
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standards for evaluating sphygmomanometers are only intended for devices that are used 
with an occluding cuff and therefore, do not cover all aspects needed for the emerging 
wearable devices. This protocol aims to provide guidelines for device developers to 
qualify and validate their products, potential purchasers or users to evaluate and select 
prospective products, and health care professionals to understand the manufacturing 
practices on wearable cuff-less BP devices. 
6.3. Subiect selection 
The summarized requirements on subject selection are presented in Table 6-1. 
TABLK (M. lUiimJlRKMKXT OX SUBJECTS SKLKCTIOX 
Total number of subjects: 
^ 
Blood pressure ranges according to classification in JNC 7 [4]: 
… 丨 S y s t o l i c BP Diastolic BP Number of 
BP C assification , u 、 , ^ , . 
(mmHg) (mmHg) Subjects 
Normal <120 and <80 15 
Prehypertension 120-139 or 80-89 15 
Stage 1 
hypertension 140-160 or 90-100 15 
Gender: 
At least 22 males and 22 females 
Age: 
All subjects should be aged between 18 to 65 years old. 
45 subjects, with at least 22 females and 22 males, aged between 18-65 years old 
shall be recruited if the device is intended for using in adults. The study participants 
were introduced to the observers, who explained them with the eligibility requirements 
and specific procedures. Initials, sex, date of birth, medical history and taking of 
medicine were recorded on the report form. 
Special groups of population, such as pregnant, pediatric or elderly; or those present 
arrhythmias are not included. Patients with stage 2 hypertension (SBP > 160mmHg or 
DBP >100 mmHg) are also excluded from the study because of the exceedingly high BP 
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variability at this extreme BP level. Independent validation is recommended to be 
conducted if the manufactures claim that their products are applicable for such groups of 
population. 
The subjects shall also have a specified range of BP. The endpoint of the BP 
classification is determined according to the JNC 7 report [4]. The BP used in the 
analysis should be the entry BP measured by a trained observer following the 
recommendation called out by BHS protocol [30]. Three measurements are required at 
the sitting position, and the averaged value is used for the analysis. 
6.4. Main validation 
Concerning the special feature of the cuff-less BP measuring devices, where the 
calibration efficacy would greatly influence the device accuracy, the validation 
procedures is considerably different from that for the cuff-based devices. The procedure 
is breakdown into three levels: static test, test with BP change from the calibration point, 
test after a certain period of time from calibration. Practitioners should properly design 
their validation protocol to cover the validation from all the three levels. 
JL Static test 
Device validation should be performed at room temperature without disturbing 
influences. The subjects are asked to relax for 10 minutes. Calibrate the test device 
according to the instruction stated by the manufacture. Recalibration is allowed if a fail-
calibration-alarm implemented in the device presents. 
After the calibration, 3 pairs of measurements, for each subject, from the test device 
and observers are carried out. Either simultaneous or sequential is allowable, depending 
on whether the inflation and deflation of the cuff used by the reference mercury 
sphygmomanometer would interfere with the test device measurement. SBP and DBP 
measurements with the mercury sphygmomanometer were determined using the phase I 
and phase V Korotkoff sounds respectively. At least 30s should be allowed after 
observes measurement to avoid venous congestion. When measurements of reference 
and test device are conducted sequentially, no more than 60s should be allowed between 
them or variability may be increased. 
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% Test witfi BCbocCjrressure cfiange 
To evaluate whether a device has been properly calibrated, the validation protocol 
should require a test that contains BP data distributing widely around the BP measured 
at calibration. For each subject, 3 pairs of measurements from the test device and 
observers are carried out. The methods and procedure of inducing the BP change is not 
restricted in the protocol, while the range and proportion of the induced change should 
be in accordance with the requirement in Table 6-2. 
t a b l e G - 2 . UliiaiJIUlilMlilXT O X T l l l i ： I M ) I J C I i : i ) B L O O l ) P R E S S U R E C U A m m S ‘ 
Changes of BP from the Point of Calibration (mmHg) 
~SBP -30- -15 - 1 5 - 0 0 - 1 5 1 5 - 3 0 
DBP -20- -10 - 1 0 - 0 0 - 1 0 1 0 - 2 0 
Required Samples 33 33 33 
(at least) 
a Blood Pressure change refers to the reference reading measured by the observers 
minus the value of at the calibration point. 
C. Test after a certainjjeriocCof time. 
In order to test whether the calibration of the device ages as well as what is claimed 
by the manufactures, the protocol shall cover an enough long period of time. This 
procedure is different from the in-use (field) validation recommended in the BHS 
protocol [30], which however aims to subject the device to a period of fairly strenuous 
use. Instead, the purpose of this phase of evaluation is to test if the device has been 
efficiently calibrated and is working at a tolerable accuracy level during the period 
between the two pints of calibration. Similar to the previous tests, 3 pairs of 
measurements for each subject from the test device and observers are carried out. 
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6.5. Data analysis and reporting 
Jl Statisticalrejjort 
The collected data are analyzed at the three test levels respectively and reported in the 
form of Table 6-3. The column of BP changes presents for the mean absolute value of 
the BP change from the calibration point. 
TABLK G-3, DKVICE ACCURACY RKPOKT 
BP Changes MAD MAPD MD SD 
(mmHg) (mmHg) (%) (mmHg) (mmHg)〔卩5(/。）CPi。（/。）CPis (/。） 
"static Test (N=135) 
Different Time Interval 
After calibration (N=135) 
一 I I I I I I I 
Before next time of calibration (N=135) 
Accuracy at different blood pressure change levels 
0-15 mmHg (N>66) 
15-30 (N>66 
According to the theoretical and mapping relationship between MAD with the 
current evaluation systems, MAD=5-6 mmHg is considered as acceptable to be 
recommended for clinical routine use. However, without much experienced accuracy 
data from the cuff-less devices, the accuracy limits are only recommended temporally. 
Modification may be needed after a reasonable large amount of devices are validated 
and reported according to this protocol. 
Moreover, the cuff-less device presents an apparent relationship between the 
difference and reference measurement. It is unfair to apply a constant accuracy limit to 
measurements at both the low and high ends of BP, because the variability may increase 
at high BP and larger "errors" were induced inevitability. Therefore, MAPD is used in 
the protocol. By using the relative difference instead of the absolute difference as the 
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calculation unit, it has the great potential to reduce the dependency of the measurement 
difference with BP level. 
In addition, the MD, SD and CP values are also required to be included in the report, 
due to the consideration of accuracy interpretation among different evaluation systems. 
Qrapfitcaf rej^resentation 
For systolic and diastolic values, the flowing graphical plots should be provided 
separately for: static test, each subset of data with specified level of BP change, and each 
subset collected at different time interval from the last time of calibration. 
• Scatter plots of the measuring differences between test device and reference 
measurement vs. the average of them, i.e. Bland-Altman plot; 
• Scatter plots of the measuring differences between test device and reference 
measurement vs. BP changes from the calibration point; 
• The histogram of BP changes for the corresponding subsets of data. 
6.6. Conclusion and future work 
In this thesis, some of the key issues concerning the evaluation of an emerging type 
of wearable cuff-less BP measuring devices were addressed, and an evaluation protocol 
was proposed based on those studies. The main contributions of this thesis include: 
• Determined the underlying distribution of the measurement difference between test 
device and the reference: t4 distribution model was proposed and testified to be 
more agreeable with the real underlying distribution of BP measuring devices, 
regardless they were cuff-based or cuff-less. This study not only provided us as a 
statistical foundation for the future development of the new standard, but also 
suggested that existing standard for the cuff-based devices may need to be 
reviewed based on the new distribution. 
• Selected new parameters to justly evaluate the accuracy: MAD or MAPD are 
recommended as a continuous scale to assess the accuracy of cuff-less devices for 
their own distinctive advantages. The relationships between the MAD with those 
parameters used in the current standards were built up based on t4 distribution. 
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Situation that the measuring difference may dependent on the BP level was 
properly addressed by the MAPD. Based on this study the accuracy criteria and 
desired number of subjects was proposed. 
• Proposed a feature oriented validation protocol: owing to the employment of a 
subject dependent BP estimation model, breakdown of the performance evaluation 
according to the change of BP from the point of calibration is crucial for 
understanding and interpreting the overall accuracy of the device. Meanwhile, 
conducting tests at different time interval from the calibration is important for 
assessing whether the calibration ages as well as it has been claimed. 
• Proposal for an evaluation standard: an integrated evaluation protocol including 
validation procedure and reporting approaches was proposed at the end of the 
thesis. Hopeftilly, more manufactures and researchers working on cuff-less devices 
will be encouraged to analyze and report their studies according to this protocol, 
and it is promising that the development of the cuff-less devices will be much 
accelerated. 
In the future, we need to further address the questions that whether the mechanism 
and method of inducing BP variation will influence the evaluation results; and what are 
the other factors that may contribute to the deviation of accuracy performance besides 
the variation of BP from the calibration point. In addition, it is desirable to find a 
substitute for the mercury sphygmomanometer or intra-arterial measurement to serve as 
a reference standard in assessing the continuous readings during motion. Lastly, as more 
experimental data become available, recommendations in this study may need to be re-
examined and modification will be taken if necessary. 
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